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Abstract

NATHAN LANCE ALDERSON. FA2H Dependent Fatty Acid 2-Hydroxylation in the
Mammalian Nervous System (Under the direction of Dr. HIROKO HAMA)
Myelin is formed by oligodendrocytes in the central nervous system and Schwann
cells in the peripheral nervous system.

This unique membrane is comprised of

approximately 70% lipid and 300/0 protein. The high lipid content is thought to be vital
for its insulatory function.

Galactosylceramide (GaICer) and sulfatide make up

approximately 30% of total myelin lipids, with more than half of these galactolipids
containing fatty acids hydroxylated at the C2 position (2-hydroxy fatty acids). Despite
their high abundance, very little is know about the biosynthesis of these 2-hydroxy
galactolipids, and specific functions of the 2-hydroxyl group in myelin galactolipids
remain speculative. To fill this gap, we recently cloned and characterized a human fatty
acid 2-hydroxylase gene, FA2H, that is highly expressed in brain. To study the roles of
fatty acid 2-hydoxylase and 2-hydroxy sphingolipids in the brain and other tissues, we
have developed highly sensitive methodo 10gies to measure in vitro fatty acid 2hydroxylase and free 2-hydroxy fatty acids by gas chromatography/mass spectrometry
(GC/MS). Utilizing these novel methods, here we demonstrate that FA2H is required for
the formation of 2-hydroxy fatty acids (precursors of 2-hydroxy galactolipids) in the
central and peripheral nervous systems, and 2-hydroxylation of free fatty acids is the first
step for the biosynthesis of 2-hydroxy galactolipids. During the course of the study we
developed FA2H knockdown using siRNA and shRNA. RNAi against FA2H revealed
unexpected cellular phenotypes indicative of altered differentiation. Cells were 2.8-fold
more migratory, exhibited increased proliferation, and were strongly resistant to cAMP

IV

induced differentiation.

These findings open an exciting area of research involving 2-

hydroxy lipids in cell growth, migration, and differentiation.

v

Introduction

A number of devastating neurodegenerative diseases, including multiple sclerosis
(MS) and certain leukodystrophies, are associated with demyelination. Myelin, a lipidrich membrane that wraps around the axons, facilitates nerve conduction and is fonned
by oligodendrocytes in the central nervous system (CNS) and Schwann cells in the
peripheral nervous system (PNS). The high lipid content of myelin is unique and thought
to be critical for insulation and function of neurons [2]. The major myelin lipids are
galactosylceramides

(GalCer)

and

sulfatides

(3-sulfate

ester of GalCer),

with

approximately one half of the total fatty acids in GalCer and sulfatides hydroxylated at
the C2 position (2-hydroxy fatty acids) [3, 4]. No other mammalian tissues contain such
high concentrations of2-hydroxy fatty acids, suggesting an important role in myelination.
Fatty acid 2-hydroxylase (FA2H) catalyzes the 2-hydroxylation of fatty acids during

de novo synthesis of ceramide, a precursor of all complex sphingolipids [4, 5]. In myelin,
the increased ratio of 2-hydroxy fatty acids to non-hydroxy fatty acids is thought to be
critical for membrane compaction, an essential process for normal nerve function [2].
Biophysical studies of 2-hydroxy sphingolipids in model membranes show that the 2hydroxyl group facilitates membrane lipid-lipid [6-8] and carbohydrate-carbohydrate
interactions between GalCer and sulfatides on apposing membranes by an extensive
network of hydrogen bonds [9, 10].

Further, in rodent brains, enzyme activities for

formation of 2-hydroxy spbingolipids increase after birth in parallel with myelination
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and decrease after peak myelination [4, 11]. These studies suggest that 2-hydroxy fatty
acids in GalCer and sulfatides have critical structural and functional roles in myelin.
Surprisingly, the biosynthetic pathway and regulation of 2-hydroxylation are not well
understood.

Elucidation

0

f this pathway is imperative for the development

0

f novel

therapeutic agents for treatment 0 f demyelinating diseases.
We recently cloned and characterized a human fatty acid 2-hydroxylase gene, FA2H,
that is highly expressed in brain [1]. We hypothesized that the FA2H gene product is
responsible for the formation of precursors for 2-hydroxy GalCerlsulfatides biosynthesis,
and that FA2H expression and activities have a critical role in myelinogenesis.
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Review of Literature

2-Hydroxy spbingolipids are found in most living organisms including vertebrate
animals, worms, plants, yeast, and some bacterial species.

In mammals, 2-hydroxy

sphingolipids are uniquely abundant in certain tissues, most notably in the nervous
system.

Galactosylceramides (GalCer) and sulfatides account for one third of myelin

lipids [2, 12].

One half of all fatty acids in these myelin glycosphingolipids are

hydroxylated at the C2 position on the N-acyl chain (2-hydroxy fatty acids) [3, 4, 13].
This modification is thought to playa critical role in electrical insulation and nerve
conduction.
The 2-hydroxy fatty acid content in postnatal mammalian brain increases with active
myelination and reaches stationary levels as animals mature [14-16].

Comparatively,

myelin forming cells contain the highest reported levels of 2-hydroxy fatty acids,
suggesting these lipids play a unique role in the myelination of the mammalian nervous
systems (CNS & PNS) [17]. However, the biosynthetic pathway and regulation of 2hydroxylation are not well understood. To this end, we recently cloned and characterized
a human fatty acid 2-hydroxylase gene, FA2H, that is highly expressed in brain [1].
2-Hydroxy Galactolipids in Vertebrate Nervous Systems.
In

m~~lin-forming

oligodendrocytes and Schwann cells, GalCer containing both 2-

hydroxy and non-hydroxy fatty acids are synthesized by the enzyme UDPgalactose:ceramide galactosyltransferase (CGT) [18]. CGT -knockout mice, which lack
3

GalCer

and

sulfatides,

form functionally

altered myelin,

develop neurological

abnormalities, and have a short life span [19-21]. Detailed studies of these mice revealed
crucial roles for GalCer and sulfatides in myelination and axo-glial organization [21-23].
Myelin of CGT -knockout mice contains 2-hydroxy glucosylceramides, which are not
found in normal myelin [19, 20].

CGT -transgenic mice also had unstable and

uncompacted myelin and developed progressive hind limb paralysis and demyelination
[24]. Although total galactolipids in these mice were not altered significantly, the ratio of
2-hydroxy GalCer to non-hydroxy GalCer was reduced, indicating that the underlying
cause of the unstable myelin was reduced 2-hydroxy GalCer. These studies underscore
the importance of2-hydroxyfatty acid-containing sphingolipids in myelin.
Biophysical Studies on 2-Hydroxy Sphingolipids.

Several biophysical studies [6, 8, 9] demonstrated that the 2-hydroxyl group in
sphingolipids has a profound effect in the lipid organization within model membranes
because of its hydrogen-bonding capability. The participation of the 2-hydroxyl group in
hydrogen bonds with neighboring lipids was shown by analysis of the crystal structure of
synthetic glycospbingolipids with 2-hydroxy octadecanoic acid [9] and by analysis of the
phase transition temperature [8]. The monolayer behavior of synthetic ceramides showed
that the 2-hydroxyl

gr~up

promotes condensation to a close-packed arrangement [6].

These studies provide a physical basis for the effects of 2-hydroxy sphingolipids in
biomembranes.
Characterization of Fatty Acid 2-Hydroxylases.

In mammals, fatty acid 2-hydroxylation is believed to occur during de novo synthesis
of ceramides, the common precursors of all glycosphingolipids and sphingomyelin.
4

Hoshi and Kishimoto first reported rat brain fatty acid 2-hydroxylase activities in 1973
[4].

The rat brain fatty acid 2-hydroxylase is a microsomal enzyme [5] that requires

molecular oxygen, Mg2+, pyridine nucleotides, cellular cofactors [4], and microsomal
electron transfer proteins [25, 26]. Despite their extensive efforts, the rat brain fatty acid
2-hydroxylase has not been purified, and biochemical study of this enzyme has not been
reported since 1990.

The biosynthetic pathway and coordination with other myelin

enzymes is still not fully understood.

Identification oftheYeast FADl gene (SCS7).
In the yeast Saccharomyces cerevisiae, most sphingolipids contain 2-hydroxy fatty
acids. The 2-hydroxylation is dependent on the FAH1 (also known as SCS7) gene, which
has been identified as a gene containing a cytochrome bs-like sequence [27] and as a
suppressor of the Ca2+-sensitive phenotype of csg2 mutants [28]. Yeast fahl mutants
show increased resistance to pore-fonning antifungal agents, presumably because of
altered plasma membrane properties [29]. Yeast Fah1 p is a member of the membranebound desaturaselhydroxylase family with the conserved histidine motif

(HX(3--4)HX(7-

41)HX(2-3)-HHX(61-189)(H/Q)X(2-3)HH), which is thought to coordinate a non-heme di-iron
cluster at an active site [30]. The reactions catalyzed by the enzymes in this family require
electron donors and molecular oxygen [30]. For yeast Fahl p, the tenninal electron donor
is likely the intramolecular cytochrome b s domain. It is notable that the predicted
properties of yeast Fah1 p are consistent with the biochemical properties of rat brain fatty
acid 2-hydroxylase. Therefore, it is a reasonable assumption that mammalian fatty acid 2hydroxylases are encoded by FAHI homologues.
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Identification of Mammalian FA2H genes.

Previously, we cloned and characterized a human gene encoding a fatty acid 2hydroxylase (FA2H) that is highly expressed in human brain [1].

BLAST sequence

analyses identified several human cDNA sequences that had significant similarity to
yeast FARl (also known as SCS7), a gene required for 2-hydroxylation of spbingolipidassociated very long chain fatty acids [27, 28, 31]. All of the eDNA clones were derived
from the same gene located in human chromosome 16 (NCBI locus identification,
79152), which we named FA2H for fatty acid 2-hydroxylase. !he FA2H gene product is
a 372-amino acid protein (42.8 kDa) that has 360/0 identity and 46% similarity to yeast
Fahlp. Yeast Fahlp contains an N-terminal cytochrome b s domain (NCBI Conserved
Domain Database accession no. pfamOOI73), four potential transmembrane domains, and
the

characteristic

histidine

desaturaseslhydroxylases

motif

conserved

among

membrane

bound

(consensus: HX(3--4)HX(7--41 )HX(2-3)-HHX( 61-89)(H/Q)X

(2-3)HH) (13,29,31). These histidines are thought to coordinate the non-heme di-iron
cluster at an active site [30] (32). Similarly, human FA2H protein contains a cytochrome
b 5 domain at its N terminus (amino acids 1-92). Within this domain is the conserved
heme-binding domain (His-Pro-Gly-Gly), suggesting that it is functional as an electron
carrier. The cytochrome b 5 domains of yeast Fahl p and human FA2H lack a membrane
anchor, which is present in the microsomal cytochrome b s. The C-terminal three quarters
of FA2H are highly homologous to the sphingolipid fatty acid hydroxylase domain
(NCBI Conserved Domain Database accession no. pfam04116). This domain is found in
previously identified FAHl homologues inSchizosaccharomyces pombe, Arabidopsis

thaliana, and Caenorhabditis elegans [27], as well as in hypothetical proteins in the fungi
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Magnaporthe grisea and Neurospora crass a, the malaria mosquito Anopheles gambiae,
Drosophila melanogaster, the nematode C. briggsae, Xenopus laevis, Mus musculus, and
Rattus norvegicus (NCBI conserved domain architecture retrieval tool). All of these
proteins contain the eight conserved histidines and an N-terminal cytochrome hs domain
with the exception of the A. thaliana homologue, which lacks a cytochrome hs domain
[27].
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Chapter 1
Development of a Novel Fatty Acid 2-Hydroxylase Assay
Introduction
Spbingolipids are a large class of lipids ubiquitously present in eukaryotic cell
membranes.

The structural diversity of sphingolipids stems from over three hundred

distinct head groups, as well as various modifications on hydrocarbon chains of the
hydrophobic ceramide moiety. One of the major modifications of ceramide structure is
2-hydroxylation of the amide-linked fatty acids. The 2-hydroxylation of the N-acyl chain
occurs during de novo synthesis of ceramide and is catalyzed by fatty acid 2-hydroxylase
(also known as fatty acid alpha-hydroxylase). Sphingolipids containing 2-hydroxylated
N-acyl chains (2-hydroxy sphingolipids) are found in various organisms, including plants,
yeast, worms, and vertebrate animals.
especially

abundant

m

the

nervous

In mammals, 2-hydroxy sphingolipids are
system,

as

the

major

myelin

lipids,

galactosylceramides and sulfatides (3-sulfate ester of galactosylceramide), contain a high
proportion (--500/0) of 2-hydroxy fatty acids [3, 4, 13]. The roles for Gale and sGalC in
myelination and axo-glial organization have been demonstrated in studies of knockout
mice that lack these lipids [21-23], and the significance of 2-hydroxylation of these
myelin lipids has long been speculated [32].

Mammalian epidermal tissues contain a

unique set of very long chain ceramides with 2-hydroxy fatty acids, which are thought to
be critical for the permeability barrier function of the epidermis [33, 34]. A number of
studies also showed 2-hydroxy sphingolipids in liver and kidney, epithelia of digestive
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tract, and other tissues (for example [35-38]).

Despite the prevalence of 2-hydroxy

sphingolipids, fatty acid 2-hydroxylase has not been studied in extraneural tissues until
recently, and physiological roles for extraneural 2-hydroxy sphingolipids are poorly
understood.
The brain fatty acid 2-hydroxylation activity was first demonstrated by the conversion
of [1- 14C] tetracosanoic acid to 2-hydroxy tetracosanoic acid in sphingolipids when
injected into rat brains [39]. Subsequently, an in vitro fatty acid 2-hydroxylase assay was
developed using [I_14C] tetracosanoic acid as a substrate, brain homogenate as an enzyme
source, and assay products analyzed by thin-layer chromatography [40].

With this

method, biochemical properties of this enzyme have been studied in rat and mouse brains
[5, 11, 25, 26, 32, 41]. The rat brain fatty acid 2-hydroxylase requires molecular oxygen,
Mg2+, pyridine nucleotides (NADPH or NADH), and microsomal electron transport
proteins [25, 26].

The rat brain fatty acid 2-hydroxylase was insensitive to carbon

monoxide, indicating that it was not a P-450 enzyme but another type of mixed function
oxygenase [41].

Although the brain enzyme was successfully characterized, the

sensitivity of the previous assay method was limited, and no activities were detected in
other tissues containing 2-hydroxy sphingolipids [41]. It was also unclear whether free
fatty acids were the substrate of the enzyme, because the assay products were detected
only as a component of2-hydroxy ceramides, and not as free 2-hydroxy fatty acids.
In a recent study we showed that the human FA2H gene encodes a fatty acid 2hydroxylase that is highly expressed in the human brain [1]. Another study showed that
mouse FA2H protein was localized in the endoplasmic reticulum and highly expressed in
the brain during active myelination, suggesting that FA2H is the enzyme responsible for
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the fonnation of 2-hydroxylated ceramide in oligodendrocytes of the mammalian brain
[42].

In the course of the study, we developed an improved in vitro fatty acid 2-

hydroxylase assay using a stable isotope and gas chromatography-mass spectrometry.
With the new assay, we showed that human FA2H converted a free fatty acid to a
corresponding free 2-hydroxy fatty acid [1]. Here we report the details of the assay and
an application of the method to a benchtop quadrapole mass spectrometer for convenient
measurements of fatty acid 2-hydroxylase activities in various biological specimens.

Materials And Methods
Materials
Fetal bovine serum was purchased from Atlanta Biologicals (Lawrenceville, GA).
Tricosanoic acid was purchased from Matreya (catalog number 1186, Pleasant Gap, P A).
Deuterated tetracosanoic acid [3,3,5,5-D4] (catalog number 71-2404-7) was purchased
from Larodan Fine Chemicals (Malmo, Sweden).

Purified human NADPH:P-450

reductase (catalog number 456078) and NADPH regenerating system solutions (catalog
numbers 451220 and 451200) were purchased from BD Biosciences Discovery Labware
(Bedford, MA). a-Cyclodextrin was purchased from Sigma (St. Louis, MO). Methanol,
acetyl chloride, and diethyl-ether (all HPLC grade) were purchased from VWR (West
Chester, PA) and the Tri-Sil Reagent (catalog number 49001) was purchased from Pierce
Biotechnology (Rockford, IL).

Cell culture
COS7 and HeLa cells were grown in Dulbecco's modified Eagle's medium
supplemented with 4.5 giL. glucose and L-glutamine, sodium pyruvate, 10% fetal bovine
serum, and 0.1 % Pen-Strep.

Cells were maintained at 5% C02 at 37°C.
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A549 cells

(human lung carcinoma) were cultured in media containing 50% Dulbecco's modified
Eagle's medium (as above) and 50% RPMI Medium 1640 supplemented with Lglutamine. When indicated, COS7 cells were transfected with pcDNA3-hFA2H [1] using
FuGene 6 Transfection Reagent (Roche Applied Science, Indianapolis, IN).
Preparation of microsomal fractions from tissue culture cells

Approximately 1 x 106 cells were harvested by trypsin-EDT A treatment and washed
twice with ice-cold Hanks Balanced Salt Solution followed by two washes with ice-cold
10 roM PBS (pH 7.4). The cell pellets were re-suspended in 1 mllysis buffer (10 roM
Tris-HCI, pH 7.4; 1% glycerol; 1 roM PMSF) and lysed by freeze-thawing, followed by
sonication (Fisher Sonic Dismembrator Model 500, amplitude 29%, 5 sec on, 0.1 sec off,
12 cycles). Celllysates were centrifuged at 1,000 x g for 5 min to remove unbroken cells
and large debris. The supernatants were centrifuged at 100,000 x g for 2 hr in a Sorvall
M120SE ultracentrifuge with an S-100 AT4 rotor to pellet microsomal fractions. The
supernatant was discarded and the membrane pellets were resuspended in 1 ml of the icecold lysis buffer by brief sonication in a Bransonic B1510MT bath sonicator. A small
aliquot was removed for protein determination, and all samples were immediately frozen
at - 70°C until analyses. Protein was quantified using a Pierce BCA Protein Assay Kit
(Rockford,IL).
Preparation of postnuclear fractions from postnatal mouse brain
,

Whole brains were immediately excised from adult mice following euthanasia then
decapitation.

The brain tissue was quickly homogenized in 1.5 ml ice-cold cell lysis

buffer (10 roM Tris-HCI, pH 7.4; 1% glycerol; 1 roM PMSF) by 30 strokes in a 2-ml
Dounce tissue grinder. All samples were immediately frozen at -70°C until the time of
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analyses. After thawing, homogenized tissue was sonicated (Fisher Sonic Dismembrator
Model 500, amplitude 290/0, 5 sec on, 0.1 sec off: 12 cycles) and cell lysates were
centrifuged at 1,000 x g for 5 min to remove unbroken cells and large debris.

The

supernatant was removed, placed on ice, and an aliquot taken for immediate protein
detennination.
2-Hydroxylation activity measurement

In a 50-ml polypropylene tube, microsomal fractions (25 to 100 J..lg protein) or crude
brain homogenate (50 J..lg protein) were added to an assay mixture containing 2.7 mM
Tris-He!, pH 7.6; 1.28 mM NADP+; 3.3 mM glucose 6-phosphate; 3.3 mM MgCh; 0.2
unit of glucose 6-phosphate dehydrogenase; 1 J.lg human NADPH:cytochrome P-450
reductase; and a substrate, 1 J..lg (2.7 nmoles) of [3,3,5,5-D4 ]-tetracosanoic acid (stock
solution was prepared as 10 J..lg/ml in 1.5 mM a-cyclodextrin) in a total volume of 1.5 mI.
The substrate was added at time-zero of activity measurement. Following gentle mixing
by swirling, the assay mixture was incubated at 37°C with shaking (100 rpm) to facilitate
the diffusion of oxygen. At the end of incubation, 1 pmole oftricosanoic acid (C23 fatty
acid) was added as an internal standard to each sample, and fatty acids were immediately
extracted three times with 2 m1 diethyl ether. Each extraction consisted of vortex mixing
and subsequent centrifugation.

The combined diethyl ether extracts were brought to

dryness under a stream of nitrogen in 13 x 100 mm screw cap test tubes (Fisher
Scientific, catalog number 14-959-25A). Fatty acids were derivatized and quantified as
described under "Measurement of fatty acid 2-hydroxylase assay product by GC/MS".
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Measurement of fatty acid 2-hydroxylase assay product by GCIMS

The methyl esters of fatty acids were prepared as previously described [1]. Briefly,
anhydrous methanolic HCI was prepared by drop-wise addition of acetyl chloride to
methanol and 1 ml added to each sample. The samples were tightly capped, incubated for
45 min at 65°C, and dried under a stream of nitrogen. The 2-hydroxy groups were further
derivatized to trimethylsilyl (TMS) ethers by the addition of 125

~l

Tri-Sil reagent and

incubated at room temperature for 30 min tightly capped.
Derivatized samples (1-2 J.11) were analyzed by one of the two GC/MS systems. For
activities in transfected COS7 cells (Figs. 2, 3, and 4), the samples were directly applied
to a Hewlett-Packard 5890 gas chromatograph with injector in splitless mode.

The

analytes were fractionated on a Restek RTX-5 column (5% diphenyl/95% dimethyl
polysiloxane, 0.25 mm I.D., 0.25

~m

D.F., 30 m) (Bellefonte, PA) and the injection port

and the transfer line were maintained at 250°C. The initial oven temperature was 110°C
with no hold time and increased to 300°C at 10°Cltnin. Mass spectra data were obtained
on a VG-70S magnetic sector mass spectrometer following electron impact (EI)
ionization. Peaks of the target analytes and internal standard were processed using the
Opus software system (Micromass Infonnation Systems, Modesto, CA).
Activities in tissue culture cells (without transfection) and mouse brain were analyzed
using a bench-top GC/MS system. Derivatized samples (1-2 J.lI) were directly applied to
a Shimadzu GC-2010 (Shimadzu Scientific, Columbia, MD) gas chromatograph with
injector in splitless mode. The analytes were fractionated on a Restek RTX-5 column
(5% dipheny1l95% dimethyl polysiloxane, 0.25 mm LD., 0.25 J.lm D.F., 30 m) and the
injection port and the transfer line were maintained at 250°C.
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The initial oven

temperature was 110°C with no hold time and increased to 300°C at 10°C/min. Mass
spectra data were obtained on a Shimadzu GCMS-QP20IO mass spectrometer following
electron impact (EI) ionization. Peaks of the target analytes and internal standard were
processed using the GC/MS Lab Solutions software (Shimadzu Scientific, Columbia,
MD).
With both GC/MS systems, calibration curves were constructed by plotting peak area
ratios of the target analytes to the internal standard against concentration, using linear
regression analysis. The ion monitored for the internal standard was 368, corresponding
to the molecular ion for C: 23 FA methyl ester.

The ions monitored for 2-hydroxy

[3,3,5,5-D4]-tetracosanoic acid had a mass of 415 and 459, corresponding to m-15 and m59, respectively.

The activities were calculated as pmoles 2-hydroxy [3,3,5,5-D4]-

tetracosanoic acid per mg protein per min.
Results And Discussion
Electron transport system for the FA2H-dependent fatty acid 2-hydroxylation
Fatty acid 2-hydroxylase activity was first demonstrated in vitro using a rat brain
homogenate [41]. The rat brain enzyme required molecular oxygen, Mg2+, and pyridine
nucleotides, which suggested that the enzyme was a mixed function oxidase [41].
Cytochrome P-450 enzymes were not implicated in this reaction, since the activity was
not inhibited by carbon monoxide [41].

In modified assays with microsomal fractions,

the rat brain fatty acid 2-hydroxylase was shown to require a microsomal electron
transfer system [41].

All

0

f these characteristics are consistent with the predicted

properties of the human FA2H gene product [1]. The nucleotide sequence of the FA2H
gene indicates that FA2H protein (372 amino acid) is a member of membrane-bound
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desaturaselhydroxylase family with the conserved non-heme di-iron-binding motif (HX(34)HX(7-41)HX(2-3)HH~61-189)(H/Q)X(2-3)HH).

The enzymes in this family catalyze diverse

reactions (desaturation, hydroxylation, epoxidation, etc.) with hydrophobic substrates
(fatty acids, sterols, sphingolipids, etc.) using molecular oxygen [30]. FA2H protein also
contains an N-terminal cytochrome b s domain, which presumably serves as an electron
carrier that feeds electrons to the putative catalytic di-iron site of the enzyme. Based on
these findings, we postulated that fatty acid 2-hydroxylation by FA2H was coupled with
microsomal electron transfer systems involving NADH:cytochrome b s reductase or
NADPH:cytochrome P-450 reductase. Since NADPH is a more effective electron donor
than NADH for the rat brain enzyme [26], our assay system included purified
recombinant human NADPH:cytochrome P-450 reductase and an NADPH regeneration
system (NADP+ + glucose 6-phosphate + glucose 6-phosphate dehydrogenase). These
components are commonly used for studies of cytochrome P-450 enzymes and are
available from commercial sources. With these components, electron transport would
occur in the following order: NADPH
NADP+

NADPH

V
A

P-450 Reductase
(reduced)

P-450 Reductase
(oxidized)

y
1'+

~

NADPH:cytochrome P-450 reductase -?

Cytochrome bs
(oxidized)
Cytochrome bs
" (reduced)

V
A

Catalytic Center
2
(Fe +)
Catalytic Center
(Fe 3 +) ~

Fatty acids

°2
H2 0

2-0H Fatty Acids

-VFA2H

Fig. 1-1. An electron transport system reconstituted in the in vitro fatty acid 2hydroxylase assay. The arrows indicate the flow of electrons. The intramolecular
cytochrome b s domain is necessary for the activity ofFA2H [1], which is believed
to serve as a component of an electron transfer system to provide electrons to the
putative catalytic iron atoms. Components of the microsomal electron transport
system in vivo remain to be determined.
Alderson. N. l. et al. J.lipid Res. 2005;46:1569-1575

15

cytochrome b s domain ofFA2H

~

the catalytic site ofFA2H (Fig. 1-1).

It is of interest that the rat brain enzyme was activated by a heat stable, water soluble
cofactor [26], which was later shown to be glucose 6-phosphate [40].

Presumably,

glucose 6-phosphate aided in regenerating NADPH from NADH+ in the previous assay
system as well.
Detection of 2-hydroxy [3,3,5,5-D4]-tetracosanoic acid by GCIMS
Rat and mouse brain fatty acid 2-hydroxylase activities were previously measured
using [1_ 14 C] tetracosanoic acid as a substrate, and the reaction product was separated
from other lipids in the samples and byproducts by multiple chromatographic processes
prior to quantification [11, 41]. To simplify the assay, we used a deuterated fatty acid
[3,3,5,5-D4]-tetracosanoic acid (C24:0) as a substrate and a high resolution GC/MS
system for identification and quantification of the reaction product. Tetracosanoic acid
was a preferred substrate by the rat brain enzyme [41]. A difficulty associated with this
substrate was the delivery of this highly hydrophobic molecule to the enzyme. The rat
brain fatty acid 2-hydroxylase was sensitive to detergents, and the substrate was coated
on the surface of Celite (diatomaceous earth) in the previous assay system [41]. In our
assay, deuterated tetracosanoic acid was dissolved in a-cyclodextrin solution, which was
known to effectively solubilize fatty acids and ceramides without interfering with
enzymatic reactions [43].

Microsomes of FA2H-transfected COS7 cells were a

convenient source of the enzyme to establish the assay system.
One J.lg of deuterated tetracosanoic acid (fc. 1.8 J.lM) was incubated with the
micro somes, an NADPH regeneration system, and NADPH:cytochrome P-450 reductase.
Fatty acids were extracted after adding 1 pmole of an internal standard, tricosanoic acid
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(C23:0), which was not present in the microsomes at detectable levels. GC/MS analysis
of the fatty acids in assay mixtures showed a new lipid compound that co-eluted with
TMS ether of 2-hydroxy tetracosanoic acid methyl ester.

The molecular ion of this

compound had a mass of 474, that was 4 mass units larger than TMS derivative of 2hydroxy tetracosanoic acid. Fragmentation of this compound generated two distinct ions
with a mass of 459 and 415, respectively, which are also 4 mass units larger than the
corresponding ions generated from the non-deuterated 2-hydroxy tetracosanoic acid
derivative (Fig. 1-2).
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Fig. 1-2. Chromatograms of trimethylsilyl ether of 2-hydroxy tetracosanoic acid
methyl ester formed in an in vitro reaction. Total ion chromatogram and selected
ion chromatograms corresponding to MW=474, m-15, and m-59 are shown. The inlet
shows the fragmentation ofTMS ether of [3,3,5,5-D4]-2-hydroxy tetracosanoic acid
methyl ester. The asterisks indicate the positions of deuterium.
Alderson, N. L. et at J. Lipid Res. 2005;46:1569-1575

Other hydroxy fatty acids were distinguishable from 2-hydroxy fatty acids based on
unique fragmentation patterns. As shown in ,Fig. 1-3, TMS derivatives of 2-hydroxy, 3hydroxy, and 2,3-dihydroxy hexadecanoic acid methyl esters and 20-hydroxy eicosanoic
17

acid methyl ester occurred at different positions, generating unique fragments. Based on
the retention time and the unique fragmentation pattern, we concluded that the lipid
species shown in Fig. 1-2 was a TMS ether of deuterated 2-hydroxy tetracosanoic acid
methyl ester. In the initial phase of this study, a high-resolution magnetic sector mass
spectrometer was used to attain the lowest detection limit to ensure the detection of low
levels of reaction products. The instrument used in this study had a limit of detection at
the sub-fino Ie level.

299----..

"

0
,,

3
o ',OCH
.

343
"

2-0H C16
MW=358

H 3 C-Si-CH 3
'---------~----CH 3

J

399

H 3 C-Si-CH 3

--- - -- - ~- - - - - CH 3

'~---175

I

3-0H C16
MW=358

o '
o,

367 - - --'

OCH 3

r---161

,

" OCH 3

I

OCH 3

,,"
-"

20-0H C20
MW=414

2,3- diOH C16
MW=446

Fig. 1-3. Fragmentation patterns of hydroxy fatty acid derivatives. The masses
of unique fragments used for GelMS quantification are shown.
Alderson, N. L. et at J. Lipid Res. 2005;46:1569-1575

With this detection method, fatty acid 2-hydroxylase activity assay was established
using microsomes of COS7 cells transiently transfected with pcDNA-FA2H. These cells
highly express the human fatty acid 2-hydroxylase and served as a convenient enzyme
source to determine the assay condition. In the presence of 50 J.1g microsomal proteins,
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formation of deuterated 2-hydroxy tetracosanoic acid was linear up to 3 hr at a substrate
conversion rate of 0.25% per hr (Fig. 1-4). It should be noted that free 2-hydroxy fatty
acids were detected as products in this assay. In the previous studies, the product was
detected only as a component of ceramide, not as a free fatty acid [41], and the direct
substrate of the enzyme remained unclear [25, 32, 41]. Although we have not tested
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Fig. 1-4. Time-course of fatty acid 2-hydroxylation. Microsomal fraction was
prepared from COS7 cells transfected with pcDNA3-hFA2H. The assay mixtures
contained 50 f.1g microsomal proteins in the presence of an NADPH regeneration
system and human NADPH:P-450 reductase. Data are shown as mean ± SD of
duplicate measurements.
AJderson, N. L. et al. J. Lipid Res. 2005;46:1569-1575

ceramide 2-hydroxylation by FA2H, the time-course shown in Fig. 1-4 provides strong
evidence that FA2H utilizes free fatty acids to generate free 2-hydroxy fatty acids. Based
on the previous studies mentioned above, it appears that accumulated free 2-hydroxy
fatty acids could be converted to 2-hydroxy ceramides, presumably by ceramide
synthases present in micro somes. Thus, a highly sensitive detection system is necessary
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to measure free 2-hydroxy fatty acids below the levels that could be utilized by ceramide
synthases.
J

2-Hydroxy tetracosanoic acid formation was also proportional to protein concentration
up to 100 J.lg of micro somes (Fig. 1-5). It should be noted that quantification of the
reaction product was performed by injecting 1-2 J.lI out of 100 J.lI of derivatized samples
into the GC/MS, which corresponds to 0.25 to 1 J.lg protein. The high sensitivity of this
assay is very useful for analysis when sample quantities are limited.
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Fig. 1-5. Fatty acid 2-hydroxylation as a function of protein concentration.
Microsomal fractions were prepared from COS7 cells transfected with pcDNA3hFA2H. The assay mixtures contained indicated amount of microsomal proteins in
the presence of an NADPH regeneration system and human NADPH:P-450 reductase.
Reaction mixtures were incubated for 120 min at 37°C. Data are shown as mean ±
SD of duplicate measurements.
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The pH profile shown in Fig. 1-6 indicated that fatty acid 2-hydroxylase activity of
FA2H-transfected COS7 microsomes was the highest at pH 7.6-7.8, which is consistent
with the optimum pH for the rat brain enzyme [41]. It should be noted that this assay is a
multi-component system involving three enzymes (FA2H, NADPH:cytochrome P-450
reductase, and glucose 6-phosphate dehydrogenase).

The linear correlation between

protein concentration and activities (Fig. 1-5) shows that FA2H is the limiting component
at pH 7.6. It is possible that the rate of electron transport could have become sub-optimal
at other pH.

-0
.CO
.-0 ,...C
I: .E
( .)

(.)

as
en

0

(.)

~

I

,..... 1.5
•m

as E.
~

-;
.....

2

1

UJ

-CD0

::r:: E 0.5
0
C.

I

N

......

~

C
.......

~

0

5.5

6.5

7.5
.pH

8.5

Fig. 1-6. pH profile of fatty acid 2-hydroxylase activity. Microsomal fractions
were prepared from COS7 cells transfected with pcDNA3-hFA2H. The reaction
mixtures contained 50 f.lg microsomal proteins in the presence of an NADPH
regeneration system, human NADPH:P-450 reductase, and 2.7 mM potassium
phosphate (pH 6.0, 7.0, or 7.5) (triangle) or 2.7 mM Tris-HCI (pH 7.0, 7.4, 7.6, 7.8,
8.0, or 8.4) (circle). Reaction mixtures were incubated for 120 min. The pH of the
reaction mixture remained unchanged at the end of incubation.
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With crude biological samples, endogenous lipids could interfere with the fatty acid 2hydroxylase assay.

Free fatty acids would compete with the deuterated substrate, and

other membrane lipids and storage lipids would affect the delivery of the deuterated
substrate to the microsomal fatty acid 2-hydroxylase. When 0.18-1.8 f.lM of de uterated
tetracosanoic acid were added in the assay with 50 J.lg of microsomal proteins of FA2Htransfected COS7 cells, formation of deuterated 2-hydroxy tetracosanoic acid was
consistent at all substrate concentrations, indicating that the presence of microsomal fatty
acids and other lipids did not interfere with the assay (Fig. 1-7). This result also indicates
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that apparent Km for tetracosanoic acid is below 0.18 J..lM, which is significantly lower
than the reported Km for the rat brain enzyme (4.2 f.lM) [41].
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These values are not

directly comparable smce different methods of substrate delivery were used (Celite
complexes versus cyclodextrin inclusion complexes). Further, the reaction product in the
previous assay was detected as 2-hydroxy ceramide, which was generated by multiple
enzymatic reactions.
When crude murine brain homogenates (50 J.lg protein) were used as enzyme sources,
2-hydroxylation was not saturated at substrate concentrations below 0.9 11M, presumably
due to a relatively high concentration of lipids in the brain (Fig. 1-7). The substrate
concentration used in this report (1.8 JlM) is appropriate for the samples we have tested.
However, other samples with higher lipid contents may require a higher concentration of
the deuterated substrate.
Fatty acid 2-hydroxylase activity measurement by a benchtop GCIMS

The assay described above was initially developed using a high-resolution magnetic
sector mass spectrometer. Although this instrument provides an unsurpassed sensitivity,
the highly specialized instrument is not commonly used in research laboratories and not
practical for routine analyses.

We therefore applied the same method to a benchtop

system with a quadrapole mass spectrometer.

Although the limit of detection on the

benchtop instrument was approximately lOa-fold higher (at the finole level) compared to
the magnetic sector mass spectrometer, the activity in FA2H-transfected COS7 cells was
readily detectable with this instrument (not shown). To test whether this instrument was
useful for various biological samples, we first measured fatty acid 2-hydroxylase
activities in mouse brains.

When whole brain homogenates (50 J.lg protein) were

incubated with the assay mixture as described above, deuterated 2-hydroxy tetracosanoic
acid was reproducibly formed (Table 1-1).
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Subsequently, activities in commonly used

cell lines, COS7, HeLa, and A549, were measured.

To our knowledge, fatty acid 2-

hydroxylase activities have never been shown in tissue culture cells. As shown in Table
I, all cell lines measured had relatively high fatty acid 2-hydroxylase activities.
Consistent with this result, we have observed free 2-hydroxy fatty acids in these cells (not
shown). It is likely that fatty acid 2-hydroxylase and 2-hydroxy sphingolipids have been
overlooked in many tissues and cell lines due to their low abundance. The new assay will
allow us to re-evaluate the presence of fatty acid 2-hydroxylase and 2-hydroxy
spbingolipids in various biological samples.
TABLE 1-1

Fatty acid 2-hydroxylase activities in tissue culture cells and mouse brain
homogenates
Samples#

FA 2-hydroxylase activity (pmolesemg-1emin- 1)

Adult mouse brain

(9.9 ± 0.9) x10-3

COS7

0.27 ± 0.02

HeLa

0.28 ± 0.03

A549

0.45 ± 0.02

For the measurement of activities in mouse brains, whole brain homogenates were used
as enzyme sources. Assay mixtures were incubated with 50 f,lg proteins for 180 min. For
the measurement of activities in tissue culture cells, microsomal fractions were used as
enzyme sources. Assay mixtures were incubated with 100 f,lg proteins for 120 min. Data
are shown as the mean ± standard deviation of triplicate measurements.
#

Alderson, N. L. et al. J. Lipid Res. 2005;46:1569-1575
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Chapter 2
Fatty Acid 2-Hydroxylation in the Central Nervous System
Introduction
2-Hydroxy fatty acid-containing spbingolipids (2-hydroxy spbingolipids) are present
in most living organisms, including yeast, some bacteria, and vertebrates. In humans and
other mammals, 2-hydroxy spbingolipids are found in much higher concentrations in
myelin and epidermal tissues, compared to other tissues.

Several lines of evidence

suggest that 2-hydroxy sphingolipids may playa crucial role in creating the special
characteristics of myelin in humans and other vertebrates.
Myelin consists of approximately 700/0 lipids and 30% proteins, as compared to 3050% lipids in most cell membranes, which presumably contributes to its high electrical
resistance [2]. One of the striking features of myelin is that approximately one-third of
all lipids consist of galactosylceramides (GalCer) and sulfatides (3-sulfate ester of
GalCer) with half of their amide-linked fatty acids hydroxylated at the C2 position (2hydro xy fatty acids) [3, 4, 13, 41].
In myelin-fonning oligodendrocytes and Schwann cells, GalCer containing both 2hydroxy and non-hydroxy fatty acids are synthesized by the enzyme UDPgalactose:ceramide galactosyltransferase (CGT) [18]. COT -knockout mice, which lack
GalCer

and

sulfatides,

form

functionally

altered

myelin,

develop neurological

abnormalities, and have a short lifespan [19, 20]. Detailed studies 0 f these mice revealed
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crucial roles for GalCer and sulfatides in myelination and axo-glial organization [21-23].
Myelin of CGT -knockout mice contains 2-hydroxy glucosylceramides, which are not
found in normal myelin [19, 20].

CGT-transgenic mice also had unstable and

uncompacted myelin and developed progressive hindlimb paralysis and demyelination
[24]. While total galactolipids in these mice were not significantly altered, the ratio of 2hydroxy GalCer to non-hydroxy GalCer was reduced, indicating that the underlying
cause of the unstable myelin was reduced 2-hydroxy GalCer. These studies underscore
the importance of2-hydroxy fatty acid-containing sphingolipids in myelin.
The precursor of all complex sphingolipids is ceramide.

For the synthesis of 2-

hydroxy galactolipids, CGT uses 2-hydroxy ceramides, which are formed by the action of
fatty acid 2-hydroxylase (also known as fatty acid a-hydroxylase) [5, 41].

In 1973,

Hoshi and Kishimoto demonstrated fatty acid 2-hydroxylase activity in rat brain [41].
The rat brain fatty acid 2-hydroxylase is a microsomal enzyme [5] that

reqUIres

molecular oxygen, Mg2+, pyridine nucleotides, cellular cofactors [41], and microsomal
electron transfer proteins [25, 26]. Despite their extensive efforts, the rat brain fatty acid
2-hydroxylase has not been purified, and its molecular identity remained elusive until
recently.

We have reported the identification and characterization of the human gene

(FA2H) encoding a fatty acid 2-hydroxylase that is highly expressed in brain [1]. Human
FA2H is a highly hydrophobic protein with an N-terminal cytochrome b s domain
essential for enzyme activity.
histidine motif conserved
[consensus:

F A2H also contains a putative catalytic site with the

among membrane-bound desaturases and hydroxylases

HX(3-4)H~7-41)HX(2-3)HHX(61-189)(H/Q)X(2-3)HH].

These histidine residues

are thought to coordinate the non-heme di-iron cluster at the active site of the enzyme
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[30]. FA2H catalyzes 2-hydroxylation of free fatty acid in vitro, which was dependent on
a reconstituted electron transport system [1]. Subsequently, Eckhardt et a1. reported that
the mouse FA2H gene was highly expressed in brain during myelination, and that FA2H
mRNA colocalizes with PLP mRNA [42]. These findings provide strong evidence that
the FA2H gene encodes the fatty acid 2-hydroxylase previously characterized by
Kishimoto and colleagues.
Despite the extensive studies on biochemical characteristics of fatty acid 2hydroyxlase, the pathway for the synthesis of 2-hydroxy galactolipids remains unclear,
because in vivo substrates of this enzyme are not clearly defined.

Based on our data

(de novo synthesis pathway)
Fatty acid
Serine + Palmitoyl GoA
FA2H
~
3-Ketosphinganine
2-0H Fatty acid
~
~
Dihydrosphingosine + 2-0H Acyl-GoA
~
2-0H Dihydroceramide

C:

~

OH

(salvage pathway)
Geramide

~Fatty acid

Sphingosine

OH
NH

HO 0
2-0H Geramide
~ GGT
2-0H Galactosylceramide (GaiGer)
~
2-0H Sulfatide

Fig. 2-1. Proposed biosynthetic pathway for 2-hydroxy sphingolipids. The de
novo pathway is identical to the biosynthesis of non-hydroxy sphingolipids, except for
the 2-hydroxylation step catalyzed by FA2H. Note that fatty acids with variable chain
lengths are incorporated into sphingolipids. UDP-galactose:ceramide galactosyl
transferase (CGT) catalyzes the synthesis of galactosyl ceramide (GaICer). The
salvage pathway may contribute to the formation of2-hydroxy ceramide from 2hydroxy fatty acid and sphingosine.
Alderson, N. L. et al. J. Lipid Res. 2006.47: 2772-2780.
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obtained in vitro, we hypothesize that FA2H fonns free 2-hydroxy fatty acids in vivo,
which serve as the precursors of 2-hydroxy galactolipids. In this report we present data
that are consistent with the pathway shown in Fig. 2-1, in which FA2H-dependent 2hydroxylation of free fatty acids is the first step in the synthesis of myelin 2-hydroxy
galacto lipids.
Materials and Methods
Materials
Fetal bovine serum was purchased from Atlanta Biologicals (Norcross, GA).
Deuterated tetracosanoic acid [3,3,5,5-04]- and odd chain fatty acids (ClS-C2S) were
purchased from Larodan Fine Chemicals (Malmo, Sweden).

Bovine sulfatides and

cerebrosides were purchased from Matreya (Pleasant Gap, P A).

Generation of anti-

human FA2H polyclonal antibodies has been reported [1]. Anti-mouse FA2H polyclonal
antibodies

were

corresponding

generated
to

in rabbits

the

(KLWDYFFHTLIPEEAHPKMQ).

using

C-terminal

a

synthetic multi-antigenic peptide
20-aa

of

mouse

FA2H

HRP-linked donkey anti-rabbit IgG (NA934), and

the ECL Western Blotting Detection Kit were purchased from Amersham Biosciences
(Piscataway, NJ).

Anti-actin polyclonal antibodies were purchased from Sigma (Saint

Louis, MO). Purified human NADPH:P-450 reductase and NADPH regenerating system
solutions were purchased from BD Biosciences Discovery Labware (Bedford, MA).
Animals
A breeding colony of C57BL/6 mice was maintained in animal care facilities of the
Medical University of South Carolina (MUSC) with water and food ad libitum.
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Mice

were treated in accordance with the MUSC Institutional Animal Care and Use Committee
(IACUC) approved procedures.
Cell Cultures
Cc?4" cedS'- ~<I were

marrira:rrie~ IIi

c7M'tf't«"contauimg

msuun «(( \-Lgrfu(), (ransrerrm

(5.5 ,....glml) , sodium selenite (40 nM), ethanolamine (2 J.lg/ml) , 1% fetal bovine

seru~

penicillin-streptomycin, and supplemented with 25% B 104 neuroblastoma-conditioned
medium as reported before [45].

Oligodendrocyte differentiation was initiated upon

removal ofBl04-conditioned medium.
Primary glial cells were isolated from newborn rat brains as described previously [45,
46].

Briefly, cells were grown for 7-10 days in the presence of 10% calf serum.

Microglia were separated by shaking the culture flasks for 30 min, plated in 6-well
dishes, and harvested for immunoblot analysis. Oligodendrocyte progenitor cells (OPCs)
were harvested by overnight shaking on a gyratory shaker at 200 rpm and resuspended in
10% calf serum and subjected to several rounds of attachment/detachment for further
enrichment.

The final OPC suspension was seeded in 6-well dishes or 100-mm dishes

coated with poly-D-Iysine.

Cells were allowed to grow in DMEM supplemented with

transferrin (50 J.lglml) , insulin (5 J.lglml) , sodium selenite (20 nM), triiodo-L-thyronine
(30 nM), and 0.5% fetal calf serum. Growth media (GM) included the growth factors
bFGF (10 ng/ml) and PDaF (10 ng/ml), and differentiation media (DM) excluded growth
factors.

Astrocyte-enriched cultures were prepared by subculturing the original mixed

glial culture devoid of most oligodendrocytes and microglia as described previously [47].
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Isolation of Mouse Brain Galactolipids
GalCer and sulfatides (2-hydroxy and non-hydroxy) were isolated as described
previously with minor modifications [20].

Briefly, whole munne brains were

homogenized using a PT1200E Polytron homogenizer with a 7-mm generator, and lipids
extracted with 19 volumes of chloroform/methanol (2: 1, v/v) [48].

The extracts were

washed with 0.2 vol of 0.9% NaCI, and the lower phase collected. Aliquots (50 mg wet
weight equivalent per sample) were used for preparative TLC.

For the isolation of

sulfatides, aliquots of lipid extracts were subjected to mild alkaline hydrolysis (in 0.5 N
KOH for 10 min at 50 e C) to remove glycerolipids [19]. TLC plates were developed in
chloroform/methanol/water (70:30:4, v/v/v) after saturation with solvent vapor for 45
mm.

Lipid spots were visualized under UV after spraying with primuline solution

(0.005% primuline in acetone/water, 80:20 v/v). Galactolipid spots (2-hydroxy and nonhydroxy) were removed from the plates and subjected to alkaline hydrolysis (in 4 N KOH
for overnight at 80 ec). Following neutralization with glacial acetic acid, fatty acids were
extracted three times with 3 ml diethyl ether, and dried under N2.

Fatty acids were

derivatized and quantified as described in the next section.

Fatty Acid Determination by Gas Chromatography/Mass Spectrometry (GC/MS)
Whole brains were immediately excised from neonatal mice after careful cervical
dislocation and decapitation. The tissue was quickly homogenized in 1.5 ml of ice-cold
cell lysis buffer (10 mM Tris-HCI, pH 7.4, 1% glycerol, and 1 mM PMSF) by 30 strokes
in a 2-ml Dounce tissue grinder. The tissue homogenate was sonicated (Fisher Sonic
Dismembrator model 500; amplitude at 29%; 5 sec on, 0.1 sec off for 12 cycles), and cell
lysates were centrifuged at 1,000 x g for 5 min to remove unbroken cells and large debris.
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The supernatant was removed, a small aliquot was taken for immediate protein
detennination, and the remaining supernatant was immediately frozen at -80°C until
analysis.

Crude cell lysate (1 ml) was mixed with a set of internal standards (CIS, C17,

C19, C21, C23 and C2S fatty acids) and free fatty acids were extracted three times with 2.5
m1 of diethyl ether.

Combined diethyl ether extracts were brought to dryness under N2

for GC/MS analysis. To prepare fatty acid methyl esters, 1 ml of methanolic Hel was
added to each sample and incubated at 65°C for 45 min, and samples were brought to
dryness under nitrogen. To prepare trimethylsilyl (TMS) derivatives of hydroxyl groups,
100 Jll Tri-Sil Reagent (Pierce Biotechnology, Rockford, IL) was added to each sample
and incubated for 30 min at room temperature.

Derivatized samples (1-2 J.lI) were

directly applied to a GC-2010 gas chromatograph (Shimadzu Scientific, Columbia, MD)
with the injector in splitless mode. The injection port and transfer line were maintained at
250°C, and analytes were fractionated on a Restek RTX-5 column (5% diphenyl and 95%
dimethyl polysiloxane; 0.25 mm inner diameter, 0.25 J.lm D.F., 30 m). The initial oven
temperature was 110°C' with no hold time, and increased to 300°C at 10 °C/min. Mass
spectra data were obtained on a Shimadzu GC/MS-QP2010 mass spectrometer following
electron impact ionization.

Peaks of the target analytes and internal standards were

processed using the GC-MS Lab Solutions software (Shimadzu Scientific). Calibration
curves were constructed by plotting peak area ratios of the target analytes to their
respective internal standard against concentration.
Fatty Acid 2-HydroxyJase Assay
Brain FA2H activity was detennined as described previously [49]. Briefly, in a 50-mJ
polypropylene tube, crude brain homogenate (50 J.lg of protein) was added to an assay
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mixture containing 2.7 mM Tris-HC~ pH 7.6, 1.28 mM NADP+, 3.3 mM glucose
6-phosphate, 3.3 mM MgCh, 0.2 unit of glucose 6-phosphate dehydrogenase, 1 J.lg of
human NADPH:cytochrome P-450 reductase, in a total volume of 1.4 mI. The substrate,

°

1 J.lg (2.7 nmol) of [3,3,5,5-D4] C 24 fatty acid (stock solution was 1 J.!g/ml in 1.5 mM ucyclodextrin), was added at time zero. After gentle mixing by swirling, the assay mixture
was incubated at 37°C for 180 min with shaking (100 rpm) to facilitate the diffusion of
oxygen. At the end of incubation, 1 pmol of C23 fatty acid (an internal standard) and 20
JlI of glacial acetic acid were added to each sample, and fatty acids were immediately
extracted three times with 2 ml of diethyl ether. The combined diethyl ether extracts were
brought to dryness under a stream of nitrogen.

Fatty acids were derivatized and

quantified as described in the "Fatty Acid Determination by Gas Chromatography/Mass
Spectrometry (GC/MS)" section.

Immunoblot Analyses
CG4 and primary glial cells were resuspended in lysis buffer (10 mM Tris-HCI, pH
7.6; 1 mM PMSF; 1% glycerol), a small aliquot removed for protein determination, and
remaining samples were mixed with an equal volume of 2x SDS-PAGE sample buffer.
Total protein levels were quantified with a Pierce BCA Protein Assay Kit (Rockford, IL).
Proteins (20 Jlg per well) were separated on 10% SDS-polyacrylamide gels, and blotted
onto nitrocellulose membranes. Membranes were blocked with TBST-milk (10 mM TrisHCI, pH' 8.0; 150 mM NaCI; 0.05% Tween 20; 5% nonfat dry milk) overnight at 4°C,
incubated with affinity purified anti-human FA2H polyclonal antibodies (1: 1000) or antiactin polyclonal antibodies (1 :200) in TBST -milk for 2 hr, washed, followed by an
incubation with HRP-linked donkey anti-rabbit IgG (1 :5,000) (Amersham Biosciences,
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Piscataway, NJ) for 1.5 hr. Membranes were washed and target proteins visualized using
the ECL Chemiluminescent Detection System (Amersham Biosciences).
Whole brains were immediately excised from adult mice after careful cervical
dislocation and decapitation. The brain tissue was quickly homogenized in 1.5 m1 of icecold cell lysis buffer (10 roM Tris-HCI, pH 7.4, 1% glycerol, and 1 roM PMSF) by 30
strokes in a 2-ml Dounce tissue grinder. The tissue homogenate was sonicated (Fisher
Sonic Dismembrator model 500; amplitude at 29%; 5 sec on, 0.1 sec off for 12 cycles),
and cell lysates were centrifuged at 1,000 x g for 5 min to remove unbroken cells and
large debris.

The supernatant was removed, a small aliquot was taken for immediate

protein determination, and the remaining supernatant was analyzed as above.
Quantitative RT-PCR (qPCR)
Murine brain was immediately excised after careful cervical dislocation and
decapitation, and homogenized using a PT1200E Polytron homogenizer with a 7-mm
generator. RNA was isolated using the QIAGEN RNeasy Lipid Tissue kit. opes were
disrupted by QIAshredder, and total RNA was isolated using the QIAGEN RNeasy kit.
cDNA was generated using the Promega AT Reverse Transcriptase kit.

Real-time

quantitative PCR (Q-PCR) was perfonned on a BioRad MyiQ single-color real-time PCR
detection system.

The primers used for each gene were as follows: for mouse PLP,

mPLP-F1 ggcagatctttggcgactac and mPLP-Rl tgagcttgatgttggcctct; for mouse FA2H,
mFA2H-F1 gtgttcctgcggctcattct and mFA2H-R1 atggtgggccttcatgttgt; for mouse CGT,
mCGT -PI aaaggcatggggatcttgtt and mCGT -R1 gccgggttgatccttgtg; for mouse 18S rRNA,
m18S-Pl gcccgaagcgtttactttga and m18S-Rl ggcctcagttccgaaaacc. A standard reaction
mixture contained 15 J.lI iQ SYBR Green Supermix (BioRad), cDNA template, and 200
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nM each of forward and reverse primers in a total volume of 30 J.!l. The mixture was first

heated at 95°C for 3 min, followed by 40 cycles of 2-step amplification (10 sec at 95°C
and 45 sec at 57°C). All reactions were performed in triplicate. For each sample, 18S
rRNA was measured as an internal standard. Threshold cycle (Ct) for each target was
obtained by BioRad MyiQ Optical System Software.
CGT, and PLP mRNA were calculated using the

~~Ct

Relative abundance of FA2H,

method [50].

Results And Discussion
We propose the pathway for the synthesis of2-hydroxy galactolipids as shown in Fig.
2-1. In this pathway, it is postulated that free fatty acids are converted to 2-hydroxy fatty
acids by FA2H, which are incorporated into ceramide, the direct precursor of myelin
GalCer. We hypothesize that the main function ofFA2H in brain is to provide precursors
of myelin 2-hydroxy galactolipids.

Thus, FA2H is expected to be present primarily in

o ligodendrocytes. In fact, FA2H mRNA has been shown to colocalize with proteolipid
protein (PLP) mRNA in mouse brain [42]. To demonstrate that FA2H protein is present
in o ligodendrocytes, we performed immunoblot analysis of glial cells.

FA2H was not

detectable in the rat oligodendrocyte cell line CG4 cultured in growth medium
(supplemented with growth factors pnGF and bFGF), but distinct bands were visible
when cells were grown in differentiation medium (with no growth factors) (Fig. 2-2).
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Fig. 2-2. FA2H is present primarily in oligodendrocytes. Total celllysates (20 f.!g
protein) of rat glial progenitor cell line C04 or rat primary cells were subjected to
SDS-PAGE, followed by immunoblot with anti-human FA2H or anti-actin polyclonal
antibodies. CG4 cells were grown in a growth medium (GM) or differentiation
medium for 2 days (DM2) or 4 days (DM4). OPC GM, oligodendrocyte progenitors
in OM; OPC DM, oligodendrocyte progenitors in DM; A, astrocytes; M, microglia.
Alderson, N. L. et at J. Lipid Res. 2006.47: 2772-2780.

Based on the rat genome database, the rat FA2H protein is 80% identical to human FA2H
with the same molecular weight (43 kDa). This is consistent with the size of the band on
the immunoblot.

Similarly, FA2H was present at a low level in rat primary

oligodendrocytes maintained in growth medium, and increased when cultured in
differentiation medium. There was no detectable FA2H in primary astrocytes, and a very
faint band was visible in primary microglia.

These results are consistent with the

presumed role ofFA2H in myelin 2-hydroxy galactolipid synthesis.
In order to validate the precursor-product relationship between fatty acids and
galactolipids in developing mouse brain, we first determined the fatty acid compositions
of myelin galactolipids in neonatal mouse brains and their changes during myelination
(Table 2-1, Table 2-2). It has been reported that in Galeer of rat brain, only a small
fraction of total fatty acids are 2-hydroxylated at the onset of myelinogenesis, and the
proportion of 2-hydroxy fatty acids increases dramatically during myelination [4]. While
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the general trend of changes in fatty acid compositions of mouse brain GalCer and
sulfatides was similar to rat brain GalCer, there were distinct differences in fatty acid
species. Most notably, mouse GaICer and sulfatide contained high levels of 2-hydroxy
Cl6

fatty acid, which was not found in rat GalCer [4]. When normalized against protein

contents, changes in total non-hydroxy fatty acids of GalCer and sulfatides were within
1.5- to 2-fold from P2 to P30.

In striking contrast, 2-hydroxy fatty acid contents in

GalCer and sulfatides increased 7- and II-fold from P2 to P20, and remained high at P30.
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Table 2-1
Fatty acid composition of GalCer in neonatal mouse brain.
Non-hydroxy Fatty Acids (nmollmg protein) a

Total non-hydroxy

Age

C16

C18

C20

C22

C24

C24:1

C26

FA

P2

862

841

20.8

11.9

96.9

95.8

6.6

1935

PI7

818

722

20.7

11.9

73.3

III

5.5

1761

P20

1232

1101

30.2

11.5

105

133

5.0

2617

P30

757

742

16.7

7.6

61.3

82.9

3.2

1671

2-Hydroxy Fatty Acids (nmollmg protein) a

Tota12-hydroxy

Age

C16

C18

C20

C22

C24

C24:1

C26

FA

P2

99.3

14.7

0.2

2.2

12.1

14.4

5.2

148

P17

125

65.1

0.2

11.6

347

20.9

5.0

574

P20

417

105

0.2

13.3

464

27.1

9.3

1036

P30

298

68.8

0.2

10.6

705

22.5

9.0

1114

GalCer were purified from whole brain, and their fatty acid compositions analyzed by
GCIMS.

a

Alderson, N. L. et at J. Lipid Res. 2006.47: 2772-2780.
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Table 2-2
Fatty acid composition of sulfatides in neonatal mouse brain.
Non-hydroxy Fatty Acids (nmollmg protein) b

Total non-hydroxy

Age

C16

C18

C20

C22

C24

C24:1

C26

FA

P2

146

120

5.8

4.2

65.4

87.0

1.4

430

P17

172

164

5.3

4.9

78.1

123

1.3

548

P20

298

330

9.4

7.6

159

200

2.7

1007

P30

279

354

11.2

7.1

107

121

1.7

881

2-Hydroxy Fatty Acids (nmollmg protein) b

Total 2-hydroxy

Age

C16

C18

C20

C22

C24

C24:1

C26

FA

P2

21.2

13.4

0.6

0.9

13.8

0.3

0.8

51

PI7

91.7

41.7

0.5

1.2

29.9

0.3

0.8

166

P20

284

151

0.9

4.6

133

0.8

2.1

576

P30

221

102

0.7

3.2

135

1.1

2.7

466

b

Sulfatides were purified from whole brain, and their fatty acid compositions analyzed

by GC/MS.
Alderson, N. L. et al. J. Lipid Res. 2006. 47: 2772-2780.
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The increase in 2-hydroxy fatty acids resulted in a marked increase in the ratio of 2hydroxy fatty acids to non-hydroxy fatty acids during myelination (Fig. 2-3). This ratio
reached a peak in sulfatides at P20 (4.8-fold higher than P2), but continued to increase in
GalCer to P30 (8.7-fold higher than P2). As in rat brain GalCer, there was a shift in
chain lengths of 2-hydroxy fatty acids in mouse brain GalCer as animals matured. The
relative content of non-hydroxy C24 fatty acid in GalCer remained consistent at 2-5% of

o
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o•
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:E:
o•
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o
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10 15 20 25 30
Age (Days)
Fig. 2-3. The 2-hydroxy fatty acid contents in brain GalCer and sulfatide
increase during postnatal myelination. Whole brains were isolated from neonatal
mice at various ages. GaICer and sulfatides were extracted from whole brain and
purified by preparative TLC. Fatty acids were liberated from GalCer and sulfatides by
alkaline hydrolysis, and quantified by GC/MS. The data are expressed as the ratio of
tota12-hydroxy fatty acids to total non-hydroxy fatty acids in GalCer (filled circle)
and sulfatide (open circle).
Alderson, N. L. et at J. Lipid Res. 2006.47: 2772-2780.

total GalCer-associated fatty acids, whereas 2-hydroxy C24 fatty acid content increased
from 0.6% to 25% from P2 to P30. The increase in 2-hydroxy C24 fatty acid content in
sulfatide was less dramatic (from 3% to 10%).
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Cellular 2-hydroxy fatty acids have been previously described only as components of
various sphingolipids, and free 2-hydroxy fatty acid levels have not been reported. If free
2-hydroxy fatty acids are the precursors of 2-hydroxy galactolipids, then free fatty acids
are expected to be present in brain with similar compositions found in myelin 2-hydroxy
galactolipids.

To test this possibility, we quantified free 2-hydroxy fatty acids in

developing mouse brain (Fig. 2-4). The three major species of free 2-hydroxy fatty acids
(2-hydroxy C16, C I 8, and C24) were the same as in 2-hydroxy GalCer and sulfatides,
indicative of a precursor-product relationship. The three major free 2-hydroxy fatty acids
increased 5- to I9-fold during postnatal myelination, presumably driving the higher rate
of incorporation into myelin galactolipids.

The relative ratio among the three major

species, however, was not precisely the same.

The high levels of C24 fatty acid in

galactolipids do not reflect free 2-hydroxy C24 fatty acids, suggesting a chain-length
preference by one or more enzymes in the pathway.

The minor 2-hydroxy fatty acid

species (C20 , C22, and C 26) increased approximately 2-fold during the same period.
Following the period of peak myelination, by P83 all 2-hydroxy fatty acids decreased to
the PI levels, and further decreased in aging animals. Non-hydroxy free fatty acid levels
increased 2- to 5-fold after birth, and remained consistent after P20 (data not shown).
Determination of tissue free fatty acids could be compromised by hydrolysis of complex
lipids by lipases during handling of the tissues.

In our measurements, however, we

observed a sharp decrease of free 2-hydroxy fatty acids after P20, while brain 2-hydroxy
galactolipids continue to increase at the same time. It is, therefore, unlikely that free 2hydroxy fatty acids were generated by degradation of tissue 2-hydroxy galactolipids. To
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provide further evidence that the increase in free 2-hydroxy fatty

~cids

represent de novo

synthesis, and not degradation of2-hydroxy galactolipids, mouse brain fatty acid 2-
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hydroxylase activities were detennined using the newly developed GC/MS-based in vitro
assay [1, 49].

The assay measures the conversion

0

f deuterated C24 fatty acid to

deuterated 2-hydroxy C24 fatty acid. This system allows for the accurate measurement of
less than 1 % conversion of the deuterated substrate. As shown in Fig. 2-5, the mouse

30
~ .--.
..,
....
> c
~
20
as:.

-- .

-e

CD i::

rn -as
CD

~o

10

~E

o

>< ...
o Q.
... c:n

. -E

.c ..

NO

c:e
u.~
Age:

1

2 14 17 20 23 46 83

Days

4 18 24 32

Months

Fig. 2-5. Fatty acid 2-hydroxylase activity is upregulated during myelination.
Total brain homogenates (50 ~g protein) were used for fatty acid 2-hydroxylase
assays. The activities are expressed as finoles of2-hydroxy [3,3,5,5-D4] C24 fatty acid
formed per mg protein per min. Data are shown as mean ± S.D. (n=5 for PI, n=I for
24 months, and n=2 for all other time points).
Alderson, N. L. et at J. Lipid Res. 2006.47: 2772-2780.

brain fatty acid 2-hydroxylase activity sharply increased after P2, and the highest activity
(5-fold increase from PI) was observed in P20 mice, which closely paralleled the changes
in free 2-hydroxy fatty acids. After P20, the FA2H activity decreased to a "maintenance
level" (--30% of peak activity) by P83, which was maintained for most of the life span of

the mouse# Thus,

jt js

highJy unJjkeJy that a sjgniJicant portjon of our measurements of
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free 2-hydroxy fatty acids is due to degradation of 2-hydroxy galactolipids. Interestingly,
the activity gradually decreased as animals aged by as much as 40% in 32-month-old
mice, compared to 4-month-old mice.
We further tested the hypothesis that FA2H is the major fatty acid 2-hydroxylase
responsible for the formation of 2-hydroxy fatty acids in mouse brain during myelination.
First, FA2H protein levels in mouse brain were determined by immunoblot. As shown in
Fig. 2-6, a weak but detectable signal was present for FA2H at P2. As in the case of rat
FA2H, the mouse FA2H protein is 81 % identical to human FA2H with a molecular
weight of 43 kDa, which is consistent with the size of the band on the immunoblot.
FA2H protein increased approximately 4-fold and 9.7-fold at P14 and P20, respectively,
followed by a slight decrease at P46. The change in FA2H protein levels coincides with
the change in brain fatty acid 2-hydroxylase activity, providing evidence that FA2H is
responsible for the activity.

Age:

2

14

20

46 Days

FA2H
p-Actin
Fig. 2-6. F A2H protein levels are upregulated during myelination. Crude brain
homogenates were subjected to SDS-P AGE, followed by immunoblot with antihuman FA2H or anti-actin polyclonal antibodies.
Alderson, N. l. et al. J. Lipid Res. 2006.47: 2772-2780.

Next we tested if FA2H is up-regulated in parallel with other myelin genes during
myelination.

It has been reported that FA2H mRNA in mouse brain increased 7-fold
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from P7 to PI4, determined by Northern blot analysis [42]. Since we were interested in
the change in FA2H expression from the onset of myelination, FA2H mRNA was
quantified by qPCR from PI through P23 mice. To compare the change of expression to
other myelin genes, CGT, and PLP mRNA levels were also measured by qPCR. CGT
encodes the enzyme responsible for the conversion of ceramides to GalCer, and thus the
expression of FA2H and CGT are expected to be coordinately up-regulated. PLP is a
structural protein of myelin, which serves as an indicator of the progression of
myelinogenesis. As shown in Fig. 2-7, mouse brain FA2H mRNA was present at much
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Fig. 2-7. FA2H expression is upregulated during myelination. Total RNA was
isolated from neonatal mouse brain, and FA2H, CGT, and PLP mRNA levels were
determined by qPCR. Data are normalized against 18S rRNA levels. Circles
represent individual animals. The mean ± S.D. of three measurements are shown.
Alderson. N. L. et al. J. Lipid Res. 2006.47: 2772-2780.

lower levels than CGT or PLP mRNA at PI, and exponentially increased during the
neonatal period of myelination, reaching on average 400-fold over PI at P20. The slight
decrease in P23 is consistent with the decrease in FA2H activity and free 2-hydroxy fatty
acid content shown above. A similar pattern was observed with CGT (130-fold average)
and PLP mRNA (800-fold average) during this time period. These data are consistent
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with the hypothesis that up-regulation of FA2H is coordinated with CGT expression to
efficiently incorporate 2-hydroxy fatty acids into myelin galactolipids.
The above data show that the brain fatty acid 2-hydroxylase activity correlates with
changes in FA2H expression and protein levels. However, there may be more than one
fatty acid 2-hydroxylase present in brain. To address this question, we tested whether
brain fatty acid 2-hydroyxlase activity was inhibited by anti-FA2H polyclonal antibodies.
As shown in Fig. 2-8A, fatty acid 2-hydroxylase activity in P20 murine brain was
inhtbited by anti-mouse FA2H antibodies in a dose dependent matter. Importantly, this
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Fig. 2-8. Brain fatty acid 2-hydroxyJase activity is inhibited by anti-FA2H
antibodies. Fatty acid 2-hydroxylase assays were performed with brain homogenates
(50 J.lg protein) ofa 20-day old mouse. A. Indicated volume of PBS (open circle) or
affinity purified anti-mouse FA2H antibodies in PBS (filled circle) were added. B.
Assays were performed in the presence of the following: C, no addition; PBS, 7.5 J.lI
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FA2H). Data are shown as mean ± S.D. of triplicate measurements.
Alderson, N. L. et al. J. Lipid Res. 2006.47: 2772-2780.
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inhibitory effect was abolished when FA2H-antibodies were preincubated with the
antigen, indicating that the inhibition was due to specific binding of the antibodies to
FA2H (Fig. 2-8B).

Antibodies against other myelin proteins (MBP and 2',3'-cyclic

nucleotide 3'-phosphodiesterase) had no effect on the brain fatty acid 2-hydroxylase
activity (data not shown). These data clearly demonstrate that FA2H is the primary fatty
acid 2-hydroxylase responsible for the formation of 2-hydroxy fatty acids in mouse brain
during myelination.
In this report we provide evidence that FA2H is responsible for the formation of 2hydroxy fatty acids during myelination, and that free 2-hydroxy fatty acids are likely
precursors of myelin 2-hydroxy galactolipids. We showed that: 1) FA2H is present in
oligodendrocytes, the myelin-forming cells of the central nervous system; 2) the fatty
acid compositions of mouse brain galactolipids gradually change during myelination such
that increasing proportions of 2-hydroxy fatty acids are incorporated; 3) the relative ratio
of 2-hydroxy versus non-hydroxy galactolipids was very low at the onset of
myelinogenesis (approximately 8% of galactolipids contained 2-hydroxy fatty acids), and
increased 6- to 8-fold by 30 days of age; 4) free 2-hydroxy fatty acid levels in mouse
brain increased 5- to 9-fold during this period, and their composition was reflected on the
fatty acids in galactolipids, consistent with a precursor-product relationship; 5) the
changes of brain free 2-hydroxy fatty acid levels coincided with FA2H-dependent fatty
acid 2-hydroxylase activity and upregulation ofFA2H expression. Altogether, these data
support the postulated pathway for the synthesis of 2-hydroxy galactolipids shown in Fig.
2-1, in which free fatty acids are converted to 2-hydroxy fatty acids by FA2H, and then
incorporated into ceramide, the drrect precursor of GalCer.
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This study, for the first time, provides strong evidence that free fatty acids are in vivo
and in vitro substrates of fatty acid 2-hydroxylase. This issue remained unclear despite
the extensive biochemical studies of this enzyme in the 1970s and 1980s. In 1973, Hoshi
and Kishimoto first reported a rat brain enzyme that converted free fatty acid to 2hydroxy ceramide, which they named fatty acid a-hydroxylase [41]. The substrates used
in most of their assays were free fatty acids, and the products were detectable only as 2hydroxy ceramides, and not as free acids. The assay thus measured the net outcome of at
least two reactions, 2-hydroxylation and ceramide synthesis; the latter presumably by
acyl CoA-independent reverse ceramidase activity [51]. In their in vitro assay, ceramide
(lignoceroyl sphingosine) did not serve as a substrate [41]. Since free 2-hydroxy fatty

acids were not detectable, and ceramide did not serve as a substrate, it was postulated that
an unidentified intermediate was 2-hydroxylated [25, 32].

Consistent with their data,

ceramide (palmitoyl sphingosine) acted neither as a substrate nor as a competitive
inhibitor in our assay (Alderson and Hama, unpublished observation). There are possible
explanations for the apparent discrepancy between Kishimoto's observations and our data
that show conversion of free fatty acid to free 2-hydroxy fatty acid. It could be due to the
differences in the detection limits for free 2-hydroxy fatty acids. In our assay, less than
1% conversion of the deuterated substrate can be accurately measured. Alternatively, in
Kishimoto's assay with fatty acid-Celite complex, the two consecutive reactions (fatty
acid 2-hydroxylation followed by ceramide synthesis) might have proceeded at an
extremely high efficiency due to the limited diffusion of 2-hydroxy fatty acid
intermediates.

In our assay, substrates were delivered as a-cyclodextrin inclusion

complexes, which are less likely to limit the diffusion of reaction products.
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It is also

possible that both free fatty acid and ceramide serve as substrates in vivo, but not under
the in vitro assay conditions used in both studies. Our current study does not address
whether ceramide is also a substrate in vivo. Since there is precedence for ceramide 2hydroxylation in Tetrahymena [52] and yeast [53, 54], this issue needs to be further
clarified in mammalian cells.

Another possible substrate is acyl CoA, which has been

used in previous studies [5, 2~J 29]/

In

th~~~ ~llUlj,~~

th' acyJ chain of the rauioactive

acyl CoA was incorporated into 2-hydroxy ceramide. However, 2-hydroxy acyl eoA was
not detected as an intermediate, and it was concluded that acyl eoA was not the direct
substrate of 2-hydroxylase [5]. Since acyl eoA is quickly hydrolyzed in the presence of
brain microsomes [55], purified enzyme would be required to clarify this issue.
In various biological systems, there are at least three types of fatty acid 2hydroxylases known to date.

One type is the di-iron-containing monooxygenases, such

as FA2H and its homologues. Database searches for homologues indicated that FA2H is
a single gene in human and mouse, and Northern blot showed a single mRNA band in all
tissues tested [1, 42]. Therefore, it is unlikely that there is a second di-iron-containing
fatty acid 2-hydroyxlase in human and mouse.

A second type is cytochrome P-450

enzymes found in bacteria [56, 57]. This class of enzymes catalyzes H 202-dependent 2hydroxylation of fatty acids, which has not been reported in any eukaryotic species. A
third type is the 2-oxoglutarate (20G)-dependent oxygenase, phytanoyl-CoA 2hydroxylase. This peroxisomal enzyme is involved in oxidation of branched-chain fatty
acids, and does not use straight-chain fatty acids [58].

Thus, FA2H is the only likely

candidate for the mouse brain fatty acid 2-h~drQxylase res.\1o\1s.ible for the formatioIl of
free 2-hydroxy fatty acids. Consistent with this prediction, our data show that the brain
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fatty acid 2-hydroxylase activity correlates with changes in FA2H expression and protein
levels, and that the activity was inhibited by anti-FA2H antibodies. Although we cannot
exclude the possibility for a second, minor fatty acid 2-hydroxylase, current data
indicates that FA2H is the major fatty acid 2-hydroxylase involved in the synthesis of
myelin 2-hydroxy galactolipids.
Interestingly, 2-hydroxy ceramides are the preferred substrate for CGT over nonhydroxy ceramides [18, 59, 60].

Other sphingolipids in myelin (sphingomyelin and

complex glycolipids) do not normally contain 2-hydroxy fatty acids, even though the
enzymes that synthesize these complex spbingolipids are not inherently incapable of
incorporating 2-hydroxy substrates. It appears that the ER localization of CGT is partly
responsible for the highly selective incorporation of 2-hydroxy fatty acids into GalCer.
Sphingomyelin synthases and GlcCer synthase are localized in the Golgi apparatus or
plasma membrane, and therefore require ceramide transport from the ER to these
organelles. If 2-hydroxy ceramides were efficiently converted to GalCer by CGT in the
ER, little or no 2-hydroxy ceramides would be transported out of the ER.

Perhaps,

expression of FA2H and CGT is precisely coordinated in oligodendrocytes such that all
2-hydroxy fatty acids generated by FA2H are incorporated into GalCer.
Another factor that might playa role in the selective incorporation of 2-hydroxy fatty
acids into GalCer is a lipid tlippase that translocates ceramides from the cytoplasmic
leatlet to the extracytoplasmic leatlet of the ER membrane. The catalytic sites of FA2H
and the yeast FAH1 gene product are predicted to be at the cytoplasmic face of the ER
membrane [1, 27, 31]. Similarly, the catalytic site of ceramide synthases are predicted to
be at the cytoplasmic face [61]. Therefore, both 2-hydroxy and non-hydroxy ceramides
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are presumably formed within the cytoplasmic leaflet of the ER membrane.

Newly

synthesized ceramides then follow one of the three routes; 1) extracted by a cytoplasmic
protein CERT to be transported to the Golgi [62], 2) transported via the vesicle-mediated
mechanism, or 3) move to the extracytoplasmic leaflet to be converted to GalCer by CGT
[63]. In the third route, the transbilayer movement of ceramides could be spontaneous
[64, 65], or catalyzed by a hypothetical ceramide flippase [61, 66].

Since 2-hydroxy

ceramides are less abundant than non-hydroxy ceramides, it seems reasonable to
postulate a ceramide flippase with a higher affinity for 2-hydroxy ceramides than for nonhydroxy ceramides for delivery of all 2-hydroxy ceramides to CGT for incorporation into
2-hydroxy GalCer.
Our data also showed that there is distinct chain length specificity for incorporation of
fatty acids into GalCer and sulfatide at different stages of myelination. The most striking
was the 40-fold increase of GalCer-associated 2-hydroxy C 24 fatty acid from P2 to P30.
A similar tendency has been reported in neonatal rat brain, although less dramatic [4].
These observations suggest that there are distinct acyl chain preferences by ceramide
synthases, CGT, and GalCer sulfotransferase.

Presumably, fatty acid elongases and

ceramide synthases are coordinately regulated with FA2H and CGT to achieve the unique
fatty acid compositions of myelin galactolipids during development. There are multiple
isoforms of fatty acid elongases [67] and ceramide synthases [61], but the specific
isoforms involved in myelin 2-hydroxy GalCer synthesis are not clearly defined. Further
molecular and biochemical investigations of FA2H, fatty acid elongases, and ceramide
synthases are needed to elucidate the biosynthesis of myelin 2-hydroxy galactolipids and
their
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Chapter 3
Fatty Acid 2-Hydroxylation in the Peripheral Nervous System
Introduction

Myelin is produced by oligodendrocytes in the central nervous system and Schwann
cells in the peripheral nervous system.

This unique membrane is comprised of

approximately 700/0 lipids and 30% proteins. The high lipid content is thought to play an
integral role in insulation and salutatory nerve conduction [2]. Although myelin proteins
have been extensively studied, still very little is known about the role of lipids in
myelinogensis. Galactosylceramides (GaICer) and sulfatides (3-sulfate ester of Galeer),
comprise approximately 25-30% of total myelin lipids [2, 12].

Interestingly, 50% of

Ga1Cer and sulfatides contain fatty acids hydroxylated at the C2 position (2-hydroxy fatty
acids) [3, 4]. No other mammalian tissues contain such high concentrations of2-hydroxy
fatty acids, suggesting an important role in myelination.
Our laboratory has published detailed studies demonstrating FA2H dependent fatty
acid 2-hydroxylation in the central nervous system during developmental myelination in
rodents [68]. Previously, others have demonstrated that fatty acid 2-hydroxylase (FA2H)
catalyzes the 2-hydroxylation of fatty acids during de novo synthesis of ceramide, a
precursor of all complex spbingolipids [4, 5].

Although biochemical studies have

demonstrated that PNS myelin contains a uniquely high content of 2-hydroxy
galactolipids [69], still very little is known about the biosynthetic pathway and functional

51

role for these lipids in the peripheral nervous system. Here we demonstrate that 1) FA2H
is highly up-regulated upon Schwann cell differentiation; 2) FA2H is highly expressed in

rat sciatic nerve during postnatal myelination and exhibits an expression pattern
consistent with other known myelin associated genes (eg. COT, Po); 3) FA2H is the
major 2-hydroxylase in the rat Schwannoma cell line D6P2T and is required for the
fonnation of 2-hydroxy galactolipids; 4) FA2H may be involved in very early
myelinogenic processes including Schwann cell migration and differentiation.
Materials and Methods
Materials

Fetal bovine serum was purchased from Atlanta Biologicals (Norcross, GA). Bovine
sulfatides, cerebrosides (kerasin, phrenosin) and glucocerebrosides were purchased from
Matreya (Pleasant Gap, PA). Deuterated tetracosanoic acid [3,3,5,5-D4]-and odd chain
fatty acids (C 15 -C25 ) were purchased from Larodan Fine Chemicals (Malmo, Sweden).
Solvents used were HPLC grade and purchased from EMD, Canada and EM Science,
Oennany. Silica gel 60 TLC plates were from Merck. Recombinant heregulin-~l

177-244

was from Genentech (South San Francisco, CA). Forskolin, dibutyryl-cAMP was
purchased from Sigma (St. Louis, MO).
Animals

Sprague-Dawley rats Fisher rats were maintained in animal care facilities of the
Medical University of South Carolina and University of Miami Miller School of
Medicine, respectively, with water and food ad libitum. Rats were treated in accordance
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with the Institutional Animal Care and Use Committee approved procedures at these
institutions.
Cell Cultures
Rat Schwann cells were obtained from sciatic nerves of 3-month old Fisher rats by the
method of Morrissey [70] with minor modifications. Nerve segments were explanted in
DMEM (Invitrogen, Carlsbad, CA) containing 10% heat-inactivated FBS (Hyclone) and
depleted of fibroblasts by sequential transplantation (2-3 times) to new plastic dishes.
After two weeks, tissue explants were dissociated with 0.25% dispase (Roche) and 0.05%
collagenase (Worthington) and the resulting cell suspension plated on dishes coated with
poly-L-Iysine (PLL; 200 Jlg/ml).

Cells were grown in DMEM containing 10% FBS

supplemented with a mixture of mitogens [2 JlM forskolin, 20 Jlg/ml bovine pituitary
extract (Biomedical Tech., Stoughton, MA), and 2.5 nM recombinant heregulin-t31 177-244
(Genentech)]. After 1 week in culture, cells were trypsinized and remaining fibroblasts
removed by a 30-min incubation with anti-Thy 1.1 antibodies (conditioned medium from
mouse hybridoma cells, ATCC) followed by addition of rabbit complement (ICN).
Primary Schwann cells from passage I to 4 (2-8 popUlation doublings) were routinely
cultured on PLL-coated dishes in medium containing mit0 gens. Isolated Schwann cells
were >98% pure based on immunostaining with anti-SIOO (Dako), a protein expressed
specifically in Schwann cells. Differentiation was stimulated by plating on 10 cm PLLlaminin coated dishes (2xI06 cells I dish) in DMEM containing 1% FBS and 1 mM
dibutyryl-cAMP (Sigma) for 3 days, as described by Harrisingh et al. [71].
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Rat Schwannoma D6P2T cells were purchased from ATCC and grown in DMEM
containing 10% FBS as recommended by the supplier and collected at approximately
60%-70% confluency.
Migration Assay
D6P2T cells (50,000 per well) were placed on the top surface of filter inserts (8 J.lm
pore) with serum-free media in 24-well culture dishes containing the same media with
100/0 FBS.

After 4 hr, non-migratory cells were removed with a cotton swab, and

migratory cells on the bottom surface of the filter were stained with bromophenol blue
and counted using light microscopy.
Isolation of Rat Sciatic Nerve Galactolipids
Rats at postnatal days 4, 7, 10, 15, 20, 30 and 60 were euthanized according to
guidelines established by the institutional IACUC committee.

Sciatic nerves were

exposed through a lateral incision in the thigh and sectioned immediately. A minimum of
three sciatic nerves (PI5, P20, P30, and P60) and a maximum of 16 nerves (P4) were
pooled to generate separate samples. At least three samples were analyzed per time point
except for P4 that consisted of only one pool. Whole nerves were homogenized in PBS
using a PT1200E Polytron with a 7-mm generator. GalCer and sulfatides (2-hydroxy and
non-hydroxy) were isolated as described by Coetzee et al [20], with minor modifications.
Lipids were extracted with 19 volumes of chloroform:methanol mixtures (2: 1, v/v) [48].
The extracts were washed with 0.2 vol of 0.9% NaCI, the lower phase collected and dried
under a N2 stream.

Dry lipid extracts were sUbjected to mild alkaline hydrolysis (0.5N

KOH for 10 min at 50°C) to remove glycerolipids [20]. TLC plates were saturated with
solvent vapors for 45 min prior to development in chloroform:methanol:water (70:30:4).
54

Lipid spots were visualized under UV after spraying with primuline solution (0.005%
primuline in acetone/water, 80:20 v/v) and identified using the corresponding standards.
Hydroxy and non-hydroxygalactolipids were removed from the plates, internal standards
added (CIS, CI7, C 19, C2I, C23, C23 and C2S fatty acids), and samples were subjected to
alkaline hydrolysis (4N, KOH, overnight at 80°C). Lipids were neutralized using glacial
acetic acid, fatty acids extracted three times with 3 mL diethyl ether, and dried under N 2.
Fatty acid determination by Gas ChromatographylMass Spectrometry (GC/MS)
Fatty acid methyl esters were prepared by adding 1 mL of methanolic HCI to each
sample and incubating at 65°C for 45 min and brought to dryness under N 2 • To prepare
trimethylsilyl (TMS) derivatives of hydroxyl groups, 100 J.lL Tri-Sil Reagent (Pierce
Biotechnology, Rockford, IL) was added and incubated for 30 min at room temperature.
Derivatized samples were applied to a GC-2010 gas chromatograph
Scientific, Columbia, MD) with the injector in splitless mode.

(Shimadzu

The injection port and

transfer line were maintained at 250°C. Analytes were fractionated on a Restek RTX-5
column (5% diphenyl and 95% dimethyl polysiloxane; 0.25 mm inner diameter, 0.25 J.lm
D.F., 30 m).
I DOC/min.

The initial oven temperature was 110°C, and increased to 300°C at

Mass spectra data were obtained on a Shimadzu GC/MS-QP2010 mass

spectrometer following electron impact ionization.

Peaks of the target analytes and

internal standards were processed using the GC-MS Lab Solutions software (Shimadzu
Scientific). Calibration curves were constructed by plotting peak area ratios of the target
analytes to their respective internal standard against concentration.
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Fatty Acid 2-hydroxylase Assay
FA2H activity was detennined in rat sciatic nerves and in D6P2T cells using the
method described previously by Alderson et al. [49].

Briefly, crude sciatic nerve or

D6P2T homogenates (50 f,lg of protein) were added to an assay mixture containing 2.7
mM Tris-HCI, pH 7.6, 1.20 mM NADP+, 3.3 mM glucose 6-phosphate, 3.3 mM MgCh,

0.2 unit of glucose 6-phosphate dehydrogenase, 1 f,lg of human NADPH:cytochrome P450 reductase, in a total volume of 1.4 mL. The substrate, 1 f.lg (2.7 nmol) of [3,3,5,5-D4]
C24 fatty acid (stock solution: 10 f,lg/mL in 1.5 mM a-cyclodextrin), was added at time
zero. After gentle mixing by swirling, the assay mixture was incubated by shaking (100
rpm) at 37°C for 180 min. At the end of the incubation, 1 pmol of C23 fatty acid was
added to each sample as an internal standard, and samples neutralized by addition of 20
JlL of glacial acetic acid. Fatty acids were extracted three times with 2 mL of diethyl
ether and combined diethyl ether extracts brought to dryness under N2. Fatty acids were
derivatized and quantified as described in the "Fatty acid detennination by Gas
Chromatography/Mass Spectrometry (GC/MS)" section.
Quantitative RT-PCR (Q-PCR)
Rats at postnatal days 4, 7, 10, 15, 20, 30 and 60 were euthanized according to
guidelines established by the institutional IACUC committee.

Sciatic nerves were

exposed through a lateral incision in the thigh and sectioned innnediately. Whole nerves
were homogenized in PBS using a PT1200E Polytron with a 7-mm generator. RNA was
isolated using the QIAGEN RNeasy Lipid Tissue kit.

Schwarm cells were disrupted

using QIAshredder mini spin columns (QIAGEN) and RNA was isolated using the
QIAGEN

RNeasy

kit.

RNA

was

quantified
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using

a

NanoDrop

ND-1000

Spectrophotometer (Nanodrop Technologies, Inc.). cDNA was generated using the BioRad iScript cDNA Synthesis kit. Real-time quantitative peR (Q-PCR) was performed on
a BioRAD MyiQ single-color real-time PCR detection system.
each gene were as follows: for rat FA2H rFA2H-Fl:

The primers used for

cca tta cta cct gca ctt tgg and

rFA2H-Rl: tct gga atg agg gtg tgg a; rat CGT rCGT-FI gtt cat ggg tce age ttg tg and
rCGT -Rl ctg gcc ggc ttt gtt agg; for rat Po rPo-FI ctg cae tgc tcc ttc tgg t and rPo-RI cet
tgg cat agt gga aga ttg; for rat 18S rRNA rI8S-FI ggc ccg aag cgt tta ctt and rI8s-Rl cgg
ccg tcc ctc tta atc.
PCR reactions were performed in a 96 well plate with a standard reaction mixture
containing 15 JlL iQ SYBR Green Supermix (Bio-Rad), cDNA template, and 200 nM
each of forward and reverse primers in a total volume of 30 JlL.
performed in triplicate.

All reactions were

The thermal cycling conditions were set at 95°C for 3 mtn,

followed by 40 cycles of 2-step amplification (10 sec at 95°C and 45 sec at 57°C). I8S
rRNA was measured as the housekeeping gene.
software.

Data were analysed using the MyiQ

Relative abundance of FA2H, COT and Po were calculated using the AACt

method [50].
Construction of hairpin shRNA expression plasmids
FA2H short hairpin RNA (shRNA) or control shRNA expresslon plasmids were
constructed for the target sequence for rat FA2H aagagattattcacttgtggt, or Control #5
from Ambion (Ambion, Austin, TX).

Each insert contained a BamHI linker, sense

strand, a loop sequence (TTCAAGAGA), antisense strand, RNA Pol III terminator, and a
HindIII linker.

Double-stranded DNA inserts were prepared by annealing 63-base

complementary synthetic oligonucleotides and cloned into BamHI and HindIII sites of
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pSilencer 5.1-U6 Retro (Ambion). The correct inserts were confinned by sequencing.
Plasmids were transfected into D6P2T using Nucleofector kit T. (amaxa, Gaithersburg,
MD).

Transfection of D6P2T cells
D6P2T cells were transfected with double stranded siRNA (2f.lg) or shRNA
expressIon plasmids (2.5Jlg) using Nucleofector kit T. (amaxa, Gaithersburg, MD)
siRNA was purchased commercially (Ambion, Austin, TX), and shRNA was constructed
as

described

above in "Construction of hairpin shRNA expression plasmids".

Transfections were performed according to the manufacturers instructions (Program T20).

Briefly, cells were collected using trypsin-EDTA at 60-70 % confluency.

Cells

were counted and approximately 2 x 106 cells were transfected for each treatment
condition, and immediately plated m 75cm2 flasks to propagate for 48 hours.
Transfection efficiency was monitored for each experiment usmg pmaxGFP and
visualization

with

fluorescence

tnlcroscopy.

Typical

experiments

averaged

approximately 80-90% transfection efficiency with high viability.
[

14

C] Acetate Metabolic Labeling in D6P2T Cells
D6P2T cells were transfected with 2.5Jlg of scrambled shRNA or FA2H-shRNA

expression plasmids using amaxa Nucleofector kit T (amaxa). After 48 hours, puromycin
( 1 J.lglml) was added to the culture media and resistant cells selected for two weeks.
Cells were grown to approximately 50% confluencyand metabolically labeled with [ 14C]
acetate (2 J.lCilml) for 48 hours.

Lipids were extracted with 19 volumes of

chloroform:methanol mixtures (2:1, v/v) [48]. The extracts were washed with 0.2 vol of
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0.9% NaCl, the lower phase collected and dried under a N2 strea.m. Dried lipid extracts .
were subjected to mild alkaline hydrolysis (O.5N KOH for 10 min at 50°C) to remove
glycerolipids [20]. TLC plates were saturated with solvent vapors for 45 min previous to
being developed in chlorofonn:methanol:water (70:30:4). A small aliquot was removed
for determination of total [ 14C] counts per sample. Equal counts were loaded for each
sample on TLC plates. Non-hydroxy and 2-hydroxy galactolipids standards were run as a
cold carrier. Lipid spots were visualized under UV after spraying with primuline solution
(0.005% primuline in acetone/water, 80:20 v/v) and identified using the corresponding
standards.

GalCer were isolated by scraping 2-hydroxy and non-hydroxy

[14 C ]-GaICer

separately, and samples were measured by liquid scintillation counter.
Results and Discussion
Myelin is formed by oligodendrocytes in the eNS and Schwann cells in the PNS.. We
have previously demonstrated that FA2H is expressed in oligodendrocytes of in the
central nervous system [68]. We further demonstrated that FA2H gene expression was
up-regulated approximately 400-fold during postnatal myelination in parallel to other
myelin associated genes.

In this report, we examined the expression of FA2H during

postnatal myelination of the peripheral nervous system utilizing quantitative-PeR (qpeR).

In order to demonstrate the relative change in gene expression, other well-

characterized PNS myelin genes were also measured.

CGT encodes the galactolipid

biosynthetic enzyme that catalyzes the formation of GalCer from ceramides. As both
genes are involved in the same biosynthetic pathway, FA2H and CGT should be
coordinately expressed during myelination. The gene Po, encodes for the major structural
protein in PNS, thus serves as a good marker of the myelinogenic process. As shown in
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Fig. 3-1. FA2H expression in rat sciatic nerve is highly upregulated during
myelination in parallel with other myelin genes.FA2H, CGT, and PO mRNA
levels in rat sciatic nerve were detennined by quantitative RT -PCR. Data were
normalized against 18S rRNA levels and expressed as mean + SD (n=5 for P7, PI0,
P20, P30, and P60, n=1 for P4).

Fig. 3-1, FA2H was expressed at relatively lower levels than either CGT or Po
respectively. However, the expression pattern and relative fold increase for FA2H was
comparable to the other genes. FA2H expression increased approximately 6-fold during
the peak myelination period, from postnatal day 4 (P4) to postnatal day 20 (P20). COT
and Po increased 3.7-fold and 6.3 fold respectively during this same period.

The

expression of all three genes quickly returned to levels measured at P4. The changes in
FA2H closely paralleled two previously characterized myelin genes, thus FA2H may be
integral for proper developmental myelination of the PNS by generating 2-hydroxy
precursors that are efficiently incorporated into myelin by CGT.
We next examined the FA2H enzyme activity in the sciatic nerve during postnatal
PNS myelination utilizing a previously published method developed in our laboratory
[49]. This assay specifically measures the conversion of deuterated

C24

free fatty acids to

deuterated C24 2-hydroxy fatty acids by GC/MS. FA2H activity increased progressively
to P20, reaching approximately 700% of activity levels measured at P4 (Fig. 3-2). There

60

was a slight decline in enzyme activities

(~20%)

after this peak myelination period,

however this decrease did not directly parallel the decline observed in FA2H gene
expressIon.

Thus, FA2H protein may remain relatively stable following peak

myelinogenesis in order to continue to produce precursors in the maintenance of
abundant myelin lipids. These data also provide in vitro evidence that rat FA2H can use
free fatty acids as a substrate, however, we cannot exclude the possibility that the enzyme
may utilize another (or mUltiple) substrates in vivo.
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Fig. 3-2. FA2H activity in the sciatic nerve increases during myelination. Fatty
acid 2-hydroxylase activity in sciatic nerve homogenates were determined using the
GC/MS-based activity assay. The mean and S.D. of data from 3-5 animals are
shown, except at day 4, which represents a pool of sciatic nerve from 4 animals.

Since the activity of FA2H remained relatively high following the peak myelination
period, this raised the possibility that 2-hydroxy lipids may continue to accumulate in
myelin after this time. To address this question we quantified the non-hydroxy and 2hydroxy fatty acids associated with GalCer and sulfatides isolated from sciatic nerve
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during postnatal myelination.

Interestingly, GalCer associated C J6 and C I8 fatty acids

were relatively high compared to other longer chain fatty acids at P4 - P20 (Fig. 3-3,
Left). However, after P20, longer chain fatty acids (C22 - C26) continually accumulate to
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Fig. 3-3. The 2-hydroxy fatty acid content of GalCer increases during
myelination. Total lipids were extracted from sciatic nerve. GalCer were purified
by TLC and fatty acid compositions detennined by GC/MS. Average and S.D. of3-4
animals are shown, except at day 4, which represents a pool of sciatic nerve from 4
animals.
P60. In contrast, GalCer-associated 2-hydroxy fatty acids were comparatively low in the
first twenty days after birth (Fig. 3-3, Right). After P20, there is a marked increase in
long chain 2-hydroxy fatty acids in GalCer, primarily C22 -C26. Taken together, these data
indicate that certain fatty acid elongases (ELOVL genes) and ceramide synthases (LASS
genes) may be coordinately up-regUlated during postnatal myelination to generate
preferred chain length substrates in the biosynthesis of GalCer and sulfatides. ELOVL6
(formerly MASR) is the major fatty acid desaturase involved in PNS myelination and
may play an integral role in fatty acid elongation during developmental myelination
[72]).
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The fatty acids associated with sulfatides demonstrated a similar pattern as observed

for GalCer, with some interesting differences.

Non-hydroxy C 16 and C I8 remained

relatively high compared to all other non-hydroxy fatty acids except C22 , which
quantitatively increased after P20 (Fig. 3-4, Left).
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Fig. 3-4. The 2-hydroxy fatty acid content of sulfatides increases during
myelination. Total lipids were extracted from sciatic nerve. Sulfatides were
purified by TLC and fatty acid compositions determined by GC/MS. Average and
S.D. of3-4 animals are shown, except at day 4, which represents a pool of sciatic
nerve from 4 animals.
hydroxy fatty acids were also different compared to GalCer, with C22 and C24 being the
prominent lipid species after P20 (Fig. 3-4, Right). The differences observed in fatty acid
chain length among GalCer and sulfatides offers direct evidence that the enzyme that
catalyze the conversion of GalCer to sulfatides in the biosynthetic pathway, GalCer
sulfotransferase, most likely has a substrate chain length specificity.
The relative total abundance of non-hydroxy and 2-hydroxy fatty acids associated with
GalCer and sulfatides changed dramatically during the postnatal myelination period.
GalCer associated 2-hydroxy fatty acids accounted for only 5-6 % of total fatty acids at
P4 (Fig 3-5, Left), and increased to over 60% by P60. In comparison, 2-hydroxy fatty
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acids also were relatively low in abundance in sulfatides at P4, and increased to
approximately 35% by P60 (Fig. 3-5, Right). The percentages reported here are in direct
agreement to previously published data on the fatty acid content of rat PNS [69].
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Fig. 3-5. Proportion of 2-0H fatty acids in gaiactolipids increases during
myelination. Individual fatty acids in TLC-purified GalCer (A) and sulfatide (B)
were determined by GCIMS. The total of all detectable non-OH (open circle) and
2-0H fatty acids (closed circle) in galactolipids were used as 100%.

During myelination of the PNS, Schwann cells are derived from the neural crest and
must migrate to the appropriate site on the axon prior to the production of myelin. Prior
to myelinogenesis, the Schwann cell must senesce, make axonal contact, and undergo
differentiation.

To determine the role of FA2H in differentiation, we isolated and

cultured rat primary Schwann cells.

After stimulation to differentiate with addition

0

f

cAMP analogues, FA2H gene expression was quantified by q-PCR and compared to
CGT and Po.

FA2H was expressed at very low levels prior to differentiation when

compared to the relative expression of CGT and po. (Fig. 3-6)

However, FA2H was

increased approximately 90-fold following differentiation. In contrast, CGT and Po were

64

stimulated only 3-4 fold. These results demonstrate that FA2H may play an important
role in cAMP mediated Schwann cell differentiation.
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Fig. 3-6. F A2B expression is highly up-regulated during rat Schwann cell
differentiation. Total RNA was isolated from adult rat whole sciatic nerves.
FA2H, CaT and Po mRNA levels were determined by quantitative RT -PCR. Data
are nonnalized against 18SrRNA. Mean and SD from three measurements are
shown.

D6P2T cells, a previously characterized rat Schwannoma cell line [73], have been
previously shown to synthesize non-hydroxy and 2-hydroxy galactolipids, and exhibit a
relatively differentiated phenotype. To detennine ifFA2H was responsible for 2-hydroxy
galactolipid fonnation, we perfonned a series of experiments to demonstrate that 1)
FA2H is the major 2-hydroxylase in the PNS and 2) FA2H is required for the
biosynthesis of 2-hydroxy galactolipids.

D6P2T cells were treated by RNAi against

FA2H using commercially available rat FA2H siRNA (Ambion) or a shRNA plasmid
construct made in our laboratory. The siRNA and shRNA each targeted the same region
ofFA2H mRNA.
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The shRNA plasmid construct was used for long-term knock-down ofFA2H, as RNAi
effects by siRNA typically last approximately 72 hours.

Cells were selected for

puromycin resistance by addition of puromycin (1 J.lg/ml) to the media for two weeks,
and the cells were then propagated and harvested.
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cells were transfected with scrambled shRNA (Control) or shRNA:FA2H (FA2H).
After 48 hours, 1 J.lg/ml puromycin was added to culture media and resistant cells
selected for two weeks. (A) Celllysates were hydrolyzed overnight and the major nonhydroxy and 2-hydroxy fatty acids (C16, CI8, C24) were quantified by GC/MS. (B)
GalCer were measured by metabolic labeling with [ 14C] actetate. GalCer was isolated
by TLC, visualized by primuline, scraped, and counted by liquid scintillation counter.
Data are mean + SD of triplicate samples.
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fatty acids were measured by GC/MS following alkaline hydrolysis.
experiment was conducted using

[14C]

A separate

acetate metabolic labeling to measure

galactolipids. As shown in Fig. 3-7A, cells transfected with shRNA directed against rat
FA2H (shRNA:FA2H) had approximately 60% lower levels of total 2-hydroxy fatty
acids compared to the scrambled control treated cells (Control). After metabolic labeling
with [14C] acetate, there was no difference in the amount of synthesized non-hydroxy
GalCer in shRNA:FA2H versus control (Fig. 3-7B). However, 2-hydroxy GalCer was
decreased approximately 35-40%. It is important to emphasize that these data are newly
synthesized lipids, thus we did not expect to see complete elimination of 2-hydroxy
galacto lipids.
To confirm that results obtained in 3-7 were not an artifact of retroviral elements in
the shRNA plasmid construct, we transfected D6P2T cells with siRNA targeted against a
homologous region of the FA2H mRNA. RNAi decreased FA2H activity by 40% when
compared to control siRNA (Fig. 3-8, A). Accordingly, total 2-hydroxy fatty acids were
decreased approximately 60% compared to control (Fig. 3-8, B). These results are in
close agreement with results obtained with shRNA treatment (Fig. 3-7A), demonstrating
that the effects of shRNA are not retroviral or puromycin dependent. Together, these
data demonstrate that FA2H is the major, ifnot the only, fatty acid 2-hydroxlyase present
in the cell line D6P2T. In addition, FA2H is required for the formation of 2-hydroxy
galacto lipids.
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As shown in Fig. 3-6, FA2H is highly up-regulated during differentiation. Prior to
differentiation, Schwann cells are highly migratory and changes in the plasma membrane
lipid composition may alter migratory processes. We perfonned cell migration assays to
determine if down-regulation of FA2H expression would affect migration of D6P2T
cells. Surprisingly, cells treated with siRNA:FA2H increased cell migration by 2.8 fold
compared to control treated cells (Fig. 3-8, C). These data suggest that FA2H may be
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Fig. 3-8. FA2H is the major 2-hydroxylase in D6P2T cells and FA2H RNAi
enhances cell migration. Cells were harvested 72 hr after transfection with control
or FA2H siRNA. (A) Fatty acid 2-hydroxylase activities in whole celllysates. The
mean and range of two measurements are shown. (B) Free 2-hydroxy fatty acid
contents were determined by GCIMS. The data include three major 2-hydroxy fatty
acids (2-0H CI6, 2-0H CI8, and 2-0H C24). (C) Cells were allowed to migrate for
4 hr before staining. The mean and S.D. of cell counts in three different views are
shown.

involved in regulating certain cell surface receptors involved in Schwann cell migration,
or FA2H may serve as a negative regulator of cell cycle arrest and differentiation. Thus,
we hypothesized that down-regulation of FA2H would alter the cellular phenotype
toward a less differentiated state and these cells may be prone to remain undifferentiated.
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Finally, to detennine if FA2H alters cellular differentiation, D6P2T cells were treated
with shRNA:FA2H or control and selected against puromycin for two weeks. Cells were
treated for 24 hours with the 100 J.1M of the cAMP analogue dibutyryl cAMP (db-cAMP).
Cells were labeled with calcein-AM and visualized by fluorescence microscopy.

As

shown in Fig. 3-9, control cells treated with db-cAMP exlubited retarded growth (59%),
characteristic of senescence and early differentiation processes.

Cells treated with

shRNA:FA2H continued to proliferate with db-cAMP treatment, with only a 17% decline
in growth. These data suggest that FA2H and 2-hydroxy lipids may serve as a regulator

of differentiation in D6P2T cells, possible by removing cells from the cell cycle. This is
the first demonstration that 2-hydroxy lipids may have roles in myelination other than
structural components of the myelin sheath.
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Fig. 3-9. FA2H RNAi delays cAMP induced cellular differentiation. D6P2T
cells were transfected with scrambled shRNA (Control) or shRNA:FA2H (FA2H).
After 48 hours, 1 J.lg/ml puromycin was added to culture media and resistant cells
selected for two weeks. (Top) Cells were treated with dibutyryl cAMP (db-cAMP)
or Sham (media) for 24 hours, and visualized by fluorescence microscopy
following addition of calcein-AM (2 J.lg/ml). (Bottom) Cells were trypsinized,
stained with bromophenol blue, and counted by hemocytometer. Data are mean +
SD of triplicate samples.
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Summary and Conclusions
Galactosylceramides (GaICer) and sulfatides account for one third of myelin lipids [2,
12]. Fifty percent of all fatty acids in these myelin glycosphingolipids are hydroxylated
at the C2 position on the N-acyl chain (2-hydroxy fatty acids) [3, 4, 13]. Although the
high content of 2-hydroxy lipids in myelin have been known to exist for over fifty years,
still very little is known about 2-hydroxy lipid biosynthesis, regulation, and functional
ro Ie in myelination.
The brain fatty acid 2-hydroxylation activity was first demonstrated by the conversion
of [1_14C] tetracosanoic acid to 2-hydroxy tetracosanoic acid in sphingolipids when
injected into rat brains [39]. Subsequently, an in vitro fatty acid 2-hydroxylase assay was
developed using [1_14C] tetracosanoic acid as a substrate, brain homogenate as an enzyme
source, and assay products analyzed by thin-layer chromatography [40].

With this

method, biochemical properties of this enzyme have been studied in rat and mouse brains
[5, 11, 25, 26, 32, 41]. The rat brain fatty acid 2-hydroxylase requires molecular oxygen,
Mg2+, pyridine nucleotides (NADPH or NADH) , and microsomal electron transport
proteins [25, 26].

The rat brain fatty acid 2-hydroxylase was insensitive to carbon

monoxide, indicating that it was not a P-450 enzyme but another type of mixed function
oxygenase [41].

Although the brain enzyme was successfully characterized, the

sensitivity of the previous assay method was limited, and no activities were detected in
other tissues containing 2-hydroxy sphingolipids [41]. It was also unclear whether free

71

fatty acids were the substrate of the enzyme, because the assay products were detected
only as a component of2-hydroxy ceramides, and not as free 2-hydroxy fatty acids.
In Chapter 1 we demonstrate the development of novel and highly sensitive GC/MSbased assays for the quantification of fatty acid 2-hydroxylase activity and 2-hydroxy
fatty acid content of biological samples. The activity assay utilizes a deuterated free fatty
acid as substrate and quantitatively measures the production of deuterated free 2-hydroxy
fatty acid.

This allows for the precise detennination of enzyme activity by using a

substrate that is identifiable in an assay mixture containing high levels of endogenous
fatty acids.

The current activity assay is over 1000-fold more sensitive than previous

methods, however the method is not without limitations.

This assay system is not

suitable for true enzymological studies or high throughput testing of various substrates
and assay conditions.

It is likely that purification of the enzyme and a simple high-

throughput assay will be necessary to address these issues in the future. In its current
fo~

the assay has allowed detailed study of the enzyme properties and measurement of

fatty acid 2-hydroxylase activities in several tissues and cell lines. Further, this assay has
provided in vitro evidence that FA2H can utilize free fatty acids as a substrate [49].
Development of this assay represents a significant contribution to the study of 2-hydroxy
lipids.
In 1973, Hoshi and Kishimoto reported fatty acid 2-hydroxylase activities rat brain
[4]. However, despite exhaustive efforts for two decades by Kishimoto and colleagues,
the enzyme has not been purified and still very little is known regarding the biosynthetic
pathway for 2-hydroxy lipids. We have reported the identification and characterization
of the human gene (FA2H) encoding a fatty acid 2-hydroxylase that is highly expressed
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in brain [1]. Human FA2H is a highly hydrophobic 42.8 kDa protein with an N-terminal
cytochrome bs domain essential for enzyme activity.

FA2H also contains a putative

catalytic site with the histidine motif conserved among membrane-bound desaturases and
hydroxylases

[consensus:

HX(3-4)HX(7-41)HX(2-3)HH~61-189)(H/Q)~2-3)HH].

These

histidine residues are thought to coordinate the non-heme di-rron cluster at the active site
of the enzyme [30]. FA2H catalyzes 2-hydroxylation of free fatty acid in vitro, which
was dependent on a reconstituted electron transport system [1]. Subsequently, Eckhardt
et al. reported that the mouse FA2H gene was highly expressed in brain during
myelination, and that FA2H mRNA colocalizes with PLP mRNA [42]. These findings
provide strong evidence that the FA2H gene encodes the fatty acid 2-hydroxylase
previously characterized by Kishimoto and colleagues.
In Chapter 2 we demonstrate the role of FA2H during developmental myelination of
the central nervous system. FA2H is expressed primarily in oligodendrocytes and protein
content increases during OPC differentiation.

FA2H dependent 2-hydroxylase activity

increased during the period of developmental myelination in parallel with increases in
FA2H protein and gene expression.

These data demonstrate that FA2H is likely

controlled at the transcriptional level. Free 2-hydroxy fatty acids were measurable during
myelination and quantitatively changed in parallel to FA2H 2-hydroxylase activity,
providing in vivo evidence that free fatty acids are the likely substrate for FA2H. The
lipid composition of brain GalCer and sulfatides were measured by GC/MS. 2-Hydroxy
fatty acid species associated with galactolipids were very similar to the composition of2hydroxy free fatty acids, providing further evidence in vivo of a precursor-product
relationship. In addition, we performed antibody blocking experiments to demonstrate
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that FA2H is the major, if not only, fatty acid 2-hydroxylase in the mammalian central
nervous system.
Myelin is produced by oligodendrocytes in the central nervous system and Schwann
cells in the peripheral nervous system. Biochemical studies have demonstrated that PNS
myelin contains a high content of2-hydroxy galactolipids similar to CNS [69]. However,
there are differences in the proteins found in each system. Po is the major protein in the
PNS, however this protein is absent in the central nervous system.

Differences in the

composition among 2-hydroxy chain lengths have been reported between the CNS and
PNS [74]. Taken together, it seems likely that there may be differences between the two
systems with regard to myelin formation, structure, and function.
In Chapter 3, we demonstrate that FA2H is highly up-regulated upon Schwann cell
differentiation and during postnatal myelination of the sciatic nerve.

Fatty acid 2-

hydroxylase activity increased during myelination in parallel to the gene expression. The
gene expression pattern was consistent with other known myelin associated genes (eg.
CGT, Po), suggesting that FA2H may play an integral role in PNS myelination.

The

composition of 2-hydroxy fatty acids associated with GalCer and sulfatides changed
during myelination, with longer chain 2-hydroxy fatty acids accumulating.

These data

suggest that fatty acid elongases (ELOVL) may be up-regulated during myelination to
provide preferred substrates for GalCer and sulfatide synthesis. We further demonstrate
that FA2H is the major 2-hydroxylase in the rat Schwannoma cell line D6P2T and is
required for the formation of,2-hydroxy galactolipids. Interestingly, we also discovered
that down-regulation of FA2H increases D6P2T cell migration and delayed cAMPinduced differentiation.

These data suggest that FA2H and 2-hydroxy lipids appear to
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playa significant role in cell cycle arrest, thus enabling continued cell migration and
pro liferation.

This body of work is a comprehensive study of FA2H dependent fatty acid 2hydroxylation in the mammalian nervous systems. However, the role of 2-hydroxy fatty
acid containing lipids in myelin cannot be adequately addressed until a FA2H knock-out
mouse is available. Future studies utilizing the FA2H knockout mouse will address the
structural role of 2-hydroxy lipids in the formation of myelin sheets, the role of FA2H in
the maintenance of myelin lipids, the role of 2-hydroxy lipids in nerve conduction, and
the effect of FA2H knock-out on oligodendrocyte and Schwann cell migration and
differentiation.
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